Database Query Results : Lycopene, ,

Lyco, Lycopene: Click to Expand ⟱
Features:
Lycopene is a naturally occurring carotenoid found predominantly in tomatoes and other red fruits and vegetables.

Antioxidant Properties:
-Lycopene is a powerful antioxidant. It helps neutralize free radicals, which can reduce oxidative stress—a factor implicated in cancer development. Possible concern about interfering with chemotherapy and radiation therapy. However this review disagrees.
Inflammation Reduction:
-Some studies suggest that lycopene may help lower levels of inflammation, another process linked to cancer progression

At supraphysiological or extremely high concentrations, lycopene may have the potential to switch from an antioxidant to a prooxidant role
-The prooxidant effect of lycopene has been observed under conditions of high oxygen tension. In vitro studies have suggested that in environments with elevated oxygen levels, lycopene might promote rather than neutralize the production of reactive oxygen species (ROS).
-The presence of metal ions (such as iron or copper) in the environment can catalyze reactions where antioxidants, including lycopene, contribute to oxidative processes. These metals can interact with lycopene, potentially leading to the formation of radicals.

The mevalonate pathway produces cholesterol and a variety of isoprenoids, which are important for maintaining cell membrane integrity, protein prenylation, and other essential cellular functions.
-One of the primary enzymes in this pathway is HMG-CoA reductase (3-hydroxy-3-methylglutaryl-coenzyme A reductase), which is the target of statin drugs used for lowering cholesterol. Some studies suggest that lycopene might downregulate the activity of HMG-CoA reductase or other enzymes in the mevalonate pathway. By doing so, lycopene could potentially reduce the synthesis of cholesterol and isoprenoids that are necessary for rapid cell proliferation—an especially relevant aspect in cancer cells.

Lycopene typically used in a 100mg/day range for cancer (inhibition of the the Melavonate Pathway)
-also has antiplatelet aggregation capability.

-Note half-life 16–20 days.
BioAv Heat processing, especially when combined with a small amount of fat, significantly enhances lycopene’s bioaccessibility and absorption. (20% under optimal conditions)
Pathways:
- ROS usually goes down, but may go up or down depending on dose and environment. Lycopene may also be modified to be a "oxdiative product" which may change the behaviour.
- Raises AntiOxidant defense in Normal Cells: ROS↓, NRF2↑, SOD↑, GSH↑, Catalase↑,
- lowers Inflammation : NF-kB↓, COX2↓, p38↓, Pro-Inflammatory Cytokines : NLRP3↓, IL-1β↓, TNF-α↓, IL-6↓, IL-8↓
- inhibit Growth/Metastases : EMT↓, MMPs↓, MMP9↓, IGF-1↓, uPA↓, VEGF↓, ROCK1↓, FAK↓, RhoA↓, NF-κB↓, ERK↓
- reactivate genes thereby inhibiting cancer cell growth : EZH2↓, P53↑, Sp proteins↓,
- cause Cell cycle arrest : TumCCA↑, cyclin D1↓, cyclin E↓, CDK2↓, CDK4↓,
- inhibits Migration/Invasion : TumCMig↓, TumCI↓, TNF-α↓, FAK↓, ERK↓, EMT↓,
- inhibits angiogenesis↓ : VEGF↓, HIF-1α↓, Integrins↓,
- Others: PI3K↓, AKT↓, JAK↓, STAT↓, Wnt↓, β-catenin↓, AMPK, ERK↓, JNK, - SREBP (related to cholesterol).
- Synergies: chemo-sensitization, chemoProtective, RadioSensitizer, RadioProtective, Others(review target notes), Neuroprotective, Cognitive, Renoprotection, Hepatoprotective, CardioProtective,

- Selectivity: Cancer Cells vs Normal Cells


Scientific Papers found: Click to Expand⟱
287- ALA,  HCA,  Lyco,    Metabolic treatment of cancer: intermediate results of a prospective case series
"highlight2" >PSA↓, one patient
"highlight2" >OS↑,

3987- betaCar,  Lyco,    Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection
- Trial, AD, NA
"highlight2" >*eff↑, A substantially greater absorption of carotenoids was observed when salads were consumed with full-fat than with reduced-fat salad dressing.

1566- betaCar,  Lyco,    Antioxidant and pro-oxidant effects of lycopene in comparison with beta-carotene on oxidant-induced damage in Hs68 cells
- in-vitro, Nor, HS68
"highlight2" >*ROS↑, beta-carotene is known to have pro-oxidant activity in vitro
"highlight2" >*ROS⇅, The present study in Hs68 cells demonstrates that lycopene can be either an antioxidant or a pro-oxidant depending on the oxidants used, and that lycopene and beta-carotene behave similarly under the in vitro oxidative conditions.
"highlight2" >*Dose?, Both the antioxidant and pro-oxidant effects of lycopene tended to be dose-dependent

4228- Lyco,    A review for the pharmacological effect of lycopene in central nervous system disorders
- Review, AD, NA - Review, Park, NA
"highlight2" >*cognitive↑, Lycopene also improves cognition and memory ability of rodents in different pathological conditions, such as diabetes, colchicine exposure, high-fat diet (HFD), and aging.
"highlight2" >*memory↑,
"highlight2" >*Inflam↓, inhibition of oxidative stress and neuroinflammation, inhibition of neuronal apoptosis, and restoration of mitochondrial function have been shown to mediate the neuroprotective effects of lycopene.
"highlight2" >*Apoptosis↓,
"highlight2" >*ROS↓,
"highlight2" >*neuroP↑,
"highlight2" >*NF-kB↓, inhibition of nuclear factor-κB (NF-κB) and c-Jun N-terminal kinase (JNK), activation of the nuclear factor erythroid 2-related factor (Nrf2) and brain-derived neurotrophic factor (BDNF) signaling, and restoration of intracellular Ca2+ homeostasis,
"highlight2" >*JNK↓,
"highlight2" >*NRF2↑,
"highlight2" >*BDNF↑,
"highlight2" >*MDA↓, 8 weeks of lycopene treatment (5 mg/kg) has been shown to reverse malondialdehyde (MDA) increase and glutathione peroxidase (GSH-Px) decrease in serum in tau transgenic mice expressing P301 L mutation
"highlight2" >*GPx↑,

4782- Lyco,    New Insights into Molecular Mechanism behind Anti-Cancer Activities of Lycopene
- Review, Var, NA
"highlight2" >AntiCan↑, From an anti-cancer perspective, lycopene is often associated with reduced risk of prostate cancer and people often look for it as a dietary supplement which may help to prevent cancer.
"highlight2" >TumCP↓, Lycopene was known to be able to suppress cancerous cell proliferation, migration, invasion and adhesion activity in cell culture studies.
"highlight2" >TumCMig↓,
"highlight2" >TumCI↓,
"highlight2" >TumCA↓,
"highlight2" >ROS↓, Such suppression was often observed with changes of cancer-related gene expression and relief of oxidative stress
"highlight2" >MMP2↓, In general, lycopene could suppress the expression of MMP-2, MMP-7, MMP-9, Sp1, IGF-1R, VEGF while increasing E-cadherin stabilization, connexin 43, nm23-H1, TIMP-1 and TIMP-2 levels
"highlight2" >MMP7↓,
"highlight2" >MMP9↓,
"highlight2" >VEGF↓,
"highlight2" >E-cadherin↑,
"highlight2" >TIMP1↑,
"highlight2" >TIMP2↑,
"highlight2" >BioAv↝, it is recommended to avoid consumption of lycopene concurrently with high dietary fiber intake as several types of dietary fiber were found to be able to reduce the bioavailability of lycopene
"highlight2" >*IL12↓, lycopene could suppress proinflammatory cytokines such as IL-12, TNF-α, IL-1, IL-1β, IL-6
"highlight2" >*TNF-α↓,
"highlight2" >*IL1↓,
"highlight2" >*IL1β↓,
"highlight2" >*IL6↓,
"highlight2" >COX2↓, Sprague Dawley rat model, lycopene treatment after induction by azoxymethane caused suppression of aberrant crypt foci, preneoplastic lesion and biomarkers such as COX-2 and iNOS expression
"highlight2" >iNOS↓,
"highlight2" >*radioP↑, lycopene before induction of DNA damage via X-irradiation as lycopene treatment after irradiation failed to show such DNA protective effect
"highlight2" >NF-kB↓, anti-cancer effect of lycopene was also observed in pancreatic cancer cells (PANC-1 cell line) whereby significant reduction of ROS, NF-κB and anti-apoptotic biomarkers (cIAP1, cIAP2 and survivin) was detected while an increment of caspase-3 and Bax:
"highlight2" >survivin↓,
"highlight2" >Casp3↑,
"highlight2" >Bax:Bcl2↑,

4781- Lyco,  5-FU,  Chemo,  Cisplatin,    Antioxidant and anti-inflammatory activities of lycopene against 5-fluorouracil-induced cytotoxicity in Caco2 cells
- in-vitro, Colon, Caco-2
"highlight2" >chemoP↑, One such useful natural antioxidant that has been widely investigated to suppress chemotherapy induced side effects of drugs such as cisplatin is lycopene
"highlight2" >Inflam↓, lycopene was found to significantly suppress inflammatory responses in CC cells by inhibiting pro-inflammatory cytokines expression like cyclooxygenase-2 (COX-2), interleukin 1β (IL-1β), IL-6 and tumor necrosis-α (TNF-α)
"highlight2" >COX2↓,
"highlight2" >IL1β↓,
"highlight2" >IL6↓,
"highlight2" >TNF-α↓,
"highlight2" >ROS↑, Our results indicated the cells treatment with 60 µg/ml lycopene significantly increased ROS generation
"highlight2" >ChemoSen↑, Furthermore, L60 and L120 seemed to enhance 5FU-induced ROS generation
"highlight2" >SOD↓, significant increase SOD activity

4780- Lyco,    Potential inhibitory effect of lycopene on prostate cancer
- Review, Pca, NA
"highlight2" >TumCP↓, Lycopene suppress the progression and proliferation
"highlight2" >TumCCA↑, Lycopene has been found to effectively suppress the progression and proliferation, arrest in-cell cycle, and induce apoptosis of prostate cancer cells in both in-vivo and in-vitro conditions.
"highlight2" >Apoptosis↑,
"highlight2" >*neuroP↑, the neuro-protective effect of lycopene, mediates the signaling pathways, by inhibiting NF-κB (nuclear factor-κB) and JNK protein (c-Jun N-terminal kinase), and activating Nrf2 (Nuclear factor erythroid 2-related factor 2) and BDNF (
"highlight2" >*NF-kB↓,
"highlight2" >*JNK↓,
"highlight2" >*NRF2↑,
"highlight2" >*BDNF↑,
"highlight2" >*Ca+2↝, as well as keeping homeostasis by restoring intracellular Ca2+
"highlight2" >*antiOx↑, most powerful and natural antioxidants, and its role in preventing prostate cancer.
"highlight2" >*AntiCan↑,
"highlight2" >*Inflam↓, Anti-inflammatory properties of lycopene depends on time, and it has been found to be through the decrease of inflammatory cytokines (i.e. IL1, IL6, IL8 and tumor necrosis factor-α (TNF-α)
"highlight2" >*IL1↓,
"highlight2" >*IL6↓,
"highlight2" >*IL8↓,
"highlight2" >*TNF-α↓,
"highlight2" >NF-kB↓, lycopene increased the expression of BCO2 enzyme in an androgen-sensitive cell line that prevented cancer cell proliferation and reduced the NF-κB activity
"highlight2" >DNAdam↓, 20 and 50 μM doses of lycopene had an effect on PC3 and DU145 cell lines in inducing apoptosis with DNA damages, and preventing cell growth and colony formation
"highlight2" >PSA↓, lycopene twice a day for 3 weeks, showed that lycopene decreases the risk and growth of prostate cancer cells, and also a decrease in the level of PSA,
"highlight2" >P53↓, down-regulation of p53, Cyclin-D1, and Nrf-2 have occurred after the incubation of prostate cancer cells with the lycopene received patient’s sera in comparison with placebo
"highlight2" >cycD1↓,
"highlight2" >NRF2↓,
"highlight2" >Akt2↓, treatment with lycopene in PC3 cancer cell lines was associated with down-regulation of AKT2 [
"highlight2" >PPARγ↓, Another anti-proliferative effect of lycopene was done by increasing PPARγ-LXRα-ABCA1signaling molecules in protein and mRNA level

4779- Lyco,    Lycopene Inhibits Reactive Oxygen Species-Mediated NF-κB Signaling and Induces Apoptosis in Pancreatic Cancer Cells
- in-vitro, PC, PANC1
"highlight2" >ROS↓, The results show that the lycopene decreased intracellular and mitochondrial ROS levels, mitochondrial function (determined by the mitochondrial membrane potential and oxygen consumption rate),
"highlight2" >NF-kB↓, NF-κB activity, and expression of NF-κB-dependent survival genes in PANC-1 cells.
"highlight2" >tumCV↓, Lycopene reduced cell viability with increases in active caspase-3 and the Bax to Bcl-2 ratio in PANC-1 cells
"highlight2" >Casp3↑,
"highlight2" >Apoptosis↑, Lycopene Induces Apoptosis in PANC-1 Cells
"highlight2" >OCR↓, Lycopene Decreases Intracellular and Mitochondrial ROS Levels and OCR in PANC-1 Cells
"highlight2" >MMP↓, Lycopene Decreases MMP in PANC-1 Cells
"highlight2" >CIP2A↓, Lycopene Decreases Expression of cIAP1, cIAP2, and Survivin in PANC-1 Cells
"highlight2" >survivin↓,
"highlight2" >Casp3↑, Thus, lycopene induces caspase-3-dependent apoptosis and increased the Bax to Bcl-2 ratio in PANC-1 cells.
"highlight2" >Bax:Bcl2↑,

4778- Lyco,    Lycopene exerts cytotoxic effects by mitochondrial reactive oxygen species–induced apoptosis in glioblastoma multiforme
- in-vitro, GBM, GBM8401
"highlight2" >BBB↑, lycopene penetration across the blood-brain barrier and its induction of apoptosis, inhibiting proliferation in GBM8401 and T98G GBM cells
"highlight2" >Apoptosis↑,
"highlight2" >TumCP↑,
"highlight2" >P53↑, lycopene promoted p53 upregulation and suppressed cyclins B and cyclin D, leading to cell cycle arrest through ROS-activated ERK pathways.
"highlight2" >CycB↓,
"highlight2" >cycD1↓,
"highlight2" >TumCCA↓,
"highlight2" >mt-ROS↑, Lycopene induced Mito-ROS accumulation in GBM cells
"highlight2" >TumCG↓, Lycopene inhibits the cell growth of GBM cells

4777- Lyco,    Lycopene Inhibits Activation of Epidermal Growth Factor Receptor and Expression of Cyclooxygenase-2 in Gastric Cancer Cells
- in-vitro, GC, AGS
"highlight2" >*antiOx↑, Lycopene is a potent antioxidant carotenoid and is responsible for the red color of fruits and vegetables.
"highlight2" >tumCV↓, Lycopene decreased cell viability and increased apoptotic indices (DNA fragmentation, apoptosis inducing factor, cleavage of caspase-3 and caspase-9, Bax/Bcl-2 ratio)
"highlight2" >DNAdam↑,
"highlight2" >Apoptosis↑,
"highlight2" >cl‑Casp3↑,
"highlight2" >cl‑Casp9↑,
"highlight2" >Bax:Bcl2↑,
"highlight2" >ROS↓, Lycopene reduced the level of intracellular and mitochondrial ROS
"highlight2" >NF-kB↓, attenuation of the DNA-binding activity of NF-κB p50/p50 and the level of COX-2 gene expression.
"highlight2" >COX2↓,
"highlight2" >EGFR↓, Lycopene Reduces ROS Levels and Inhibits EGFR/Ras/ERK and p38 MAPK Signaling in AGS Cells
"highlight2" >p38↓,

4230- Lyco,    Supplementation of lycopene attenuates oxidative stress induced neuroinflammation and cognitive impairment via Nrf2/NF-κB transcriptional pathway
- in-vivo, AD, NA
"highlight2" >*BDNF↑, LYC ameliorated histopathological damage and restored brain derived neurotrophic factor (BDNF) levels in the hippocampus of mice.
"highlight2" >*antiOx↑, LYC also significantly elevated antioxidant enzymes activities and reduced levels of inflammatory cytokines in the d-galactose-treated mice serum.
"highlight2" >*Inflam↓,
"highlight2" >*HO-1↑, LYC treatment activated the mRNA expressions of antioxidant enzymes HO-1 and NQO-1, and downregulated inflammatory cytokines IL-1β and TNF-α
"highlight2" >*NQO1↑,
"highlight2" >*IL1β↓,
"highlight2" >*TNF-α↓,
"highlight2" >*ROS↓, LYC attenuated neuronal oxidative damage through activation of Nrf2 signaling
"highlight2" >*NRF2↑,
"highlight2" >*cognitive↑, LYC could ameliorate oxidative stress induced neuroinflammation and cognitive impairment possibly via mediating Nrf2/NF-κB transcriptional pathway.
"highlight2" >*BBB↑, LYC exerts antioxidant and anti-inflammatory effects both in vitro and in vivo and possesses blood brain barrier permeability

4229- Lyco,    Implicating the role of lycopene in restoration of mitochondrial enzymes and BDNF levels in β-amyloid induced Alzheimer׳s disease
- in-vivo, AD, NA
"highlight2" >*antiOx↑, beneficial therapeutic effects, which include anti-oxidant, neuro-protective and anti-cancer effects
"highlight2" >*neuroP↑,
"highlight2" >*AntiCan↑,
"highlight2" >*memory↑, Chronic administration of lycopene resulted in an improvement in memory retention, attenuation of mitochondrial-oxidative damage, reduced neuro-inflammation and restoration of BDNF level in β-A1-42 treated rats.
"highlight2" >*ROS↓,
"highlight2" >*BDNF↑,
"highlight2" >*cognitive↑, lycopene helps to protect β-A1-42 induced cognitive dysfunction and modulates amyloidogenesis.

3530- Lyco,    Lycopene Scavenges Cellular ROS, Modulates Autophagy and Improves Survival through 7SK snRNA Interaction in Smooth Muscle Cells
- in-vitro, Stroke, NA
"highlight2" >*ROS↓, The reactive oxygen species (ROS) were reduced from 8 fold to 3 fold post addition of lycopene for 24 h.
"highlight2" >*antiOx↑, Lycopene administration during ischemic heart disease might improve the functions of the smooth muscle cells and 7SK snRNA might be involved in the binding of lycopene and its antioxidant protective effects.
"highlight2" >*TNF-α↓, Addition of Lycopene to the media showed diminished TNF-α expression (p < 0.0429) compared to the stressed group.

4227- Lyco,    Lycopene Alleviates Depression-Like Behavior in Chronic Social Defeat Stress-Induced Mice by Promoting Synaptic Plasticity via the BDNF-TrkB Pathway
- in-vivo, NA, NA
"highlight2" >*BDNF↑, suggesting that lycopene may enhance synaptic plasticity via the BDNF–TrkB/pTrkB signaling pathway.
"highlight2" >*TrkB↑,
"highlight2" >*PSD95↑, mRNA expression levels of PSD‐95 and Syn in the hippocampus of the CSDS + LYC group mice were substantially upregulated compared to the model group

4784- Lyco,    Protective effects of lycopene in cancer, cardiovascular, and neurodegenerative diseases: An update on epidemiological and mechanistic perspectives
- Review, Diabetic, NA - Review, CardioV, NA
"highlight2" >*antiOx↑, Owing to its potent antioxidant properties, lycopene can potentially alleviate enhanced levels of proinflammatory mediators (e.g., proinflammatory cytokines IL-8, -6, and -1, and oxidized phospholipids) and prevent NF-κB activation
"highlight2" >*IL8↓,
"highlight2" >*IL6↓,
"highlight2" >*IL1↓,
"highlight2" >*NF-kB↓,
"highlight2" >Inflam↓, graphical abstract
"highlight2" >cycD1↓,
"highlight2" >MMP2↓,
"highlight2" >MMP9↓,
"highlight2" >Bcl-2↓,
"highlight2" >NF-kB↓,
"highlight2" >*Nrf1↑, normal cells
"highlight2" >*antiOx↑,
"highlight2" >*BDNF↑,
"highlight2" >*neuroP↑,
"highlight2" >*cardioP↑,
"highlight2" >ROS↑, i) enhanced oxidative stress due to prooxidant activities of lycopene under circumstances of tumor cell
"highlight2" >Dose↝, There are no known adverse effects from low (12 mg/day) to very high (150 mg/day) intake of dietary or formulated lycopene in a healthy population

3828- Lyco,    Lycopene alleviates oxidative stress via the PI3K/Akt/Nrf2pathway in a cell model of Alzheimer's disease
- in-vitro, AD, M146L
"highlight2" >*ROS↓, Lycopene alleviated OS and apoptosis, activated the PI3K/Akt/Nrf2 signaling pathway, upregulated antioxidant and antiapoptotic proteins and downregulated proapoptotic proteins.
"highlight2" >*PI3K↑,
"highlight2" >*Akt↑,
"highlight2" >*NRF2↓,
"highlight2" >*antiOx↑,
"highlight2" >*BACE↓, lycopene inhibited β -secretase (BACE) activity in M146L cells.
"highlight2" >*MDA↓,

3816- Lyco,  Lut,  Zeax,    Serum lycopene, lutein and zeaxanthin, and the risk of Alzheimer's disease mortality in older adults
- Review, AD, NA
"highlight2" >*Risk↓, high serum levels of lycopene and lutein+zeaxanthin at baseline were associated with a lower risk of AD mortality after adjustment for potential covariates.

3533- Lyco,  Chemo,    Lycopene and chemotherapy toxicity
- Review, Var, NA
"highlight2" >*ROS↓, Lycopene is a major carotenoid present in tomatoes, and it is a potent antioxidant that may provide protection against cellular damage caused by ROS.
"highlight2" >*antiOx↑,
"highlight2" >*chemoP↑, Lycopene may reduce or prevent the side effects of chemotherapy due to its antioxidant and anti-inflammatory properties.
"highlight2" >*Inflam↓,

3532- Lyco,    Lycopene alleviates oxidative stress via the PI3K/Akt/Nrf2pathway in a cell model of Alzheimer’s disease
- in-vitro, AD, NA
"highlight2" >*ROS↓, Lycopene alleviated OS and apoptosis, activated the PI3K/Akt/Nrf2 signaling pathway, upregulated antioxidant and antiapoptotic proteins and downregulated proapoptotic proteins.
"highlight2" >*PI3K↑,
"highlight2" >*Akt↑,
"highlight2" >*NRF2↑,
"highlight2" >*antiOx↑,
"highlight2" >*Aβ↓, Lycopene possibly prevents Aβ-induced damage by activating the PI3K/Akt/Nrf2 signaling pathway and reducing the expression of BACE in M146L cells.
"highlight2" >*Apoptosis↓, Lycopene alleviates apoptosis in M146L cells
"highlight2" >*neuroP↑, lycopene shows the neuroprotective effects of antioxidative damage and antiapoptotic by reducing the phosphorylation of PI3K/Akt

3531- Lyco,    Lycopene attenuates the inflammation and apoptosis in aristolochic acid nephropathy by targeting the Nrf2 antioxidant system
- in-vivo, Nor, NA
"highlight2" >*NRF2↑, After LYC intervened in the body, it activated Nrf2 nuclear translocation and its downstream HO-1 and NQO1 antioxidant signaling pathways
"highlight2" >*HO-1↑, Lycopene activates Nrf2-HO-1 antioxidant pathway to inhibit oxidative stress injury induced by AAI exposure in NRK52E cells
"highlight2" >*NQO1↑,
"highlight2" >*ROS↓, LYC inhibited ROS production by renal tubular epithelial cells, and alleviated mitochondrial damage.
"highlight2" >*mtDam↓,
"highlight2" >*Bcl-2↑, LYC was able to up-regulate the expression of Bcl-2, down-regulate Bax expression and inhibit the activation of cleaved forms of Caspase-9 and Caspase-3, which finally attenuated the apoptosis
"highlight2" >*BAX↓,
"highlight2" >*Casp9↓,
"highlight2" >*Casp3↓,
"highlight2" >*Apoptosis↓,
"highlight2" >*RenoP↑, Interestingly, there was a significant improvement in damaged renal tissue in mice with AAN after lycopene intervention
"highlight2" >*lipid-P↓, lycopene significantly decreased the expression of AAI-induced lipid peroxidation product (MDA), and increased the expression of antioxidant enzyme systems (T-AOC, SOD, and GSH-PX)
"highlight2" >*SOD↑,
"highlight2" >*GPx↑,
"highlight2" >*Inflam↓, Lycopene improves inflammatory responses in the kidneys of AAN mice
"highlight2" >*TNF-α↓, TNF-α, IL-6, IL-10, was increased and the expression of IL-12 was decreased in the kidneys of model mice compared with the control group. However, LYC intervention reversed the expression of these genes in a dose-dependent manner
"highlight2" >*IL6↓,
"highlight2" >*IL10↓,

3529- Lyco,    The antioxidant and anti-inflammatory properties of lycopene in mice lungs exposed to cigarette smoke
- in-vivo, Nor, NA
"highlight2" >*antiOx↑, Lycopene is a carotenoid with known antioxidant and anti-inflammatory properties.
"highlight2" >*Inflam↓,
"highlight2" >*ROS↓, Lycopene concentrations of 1 μM and 2 μM were able to reduce the production of ROS in 24 h compared with CS.
"highlight2" >*TNF-α↓, There was an increase in the levels of tumor necrosis factor-α, interferon-γ and interleukin-10 after exposure to CS, and these effects were suppressed by both doses of lycopene.
"highlight2" >*IFN-γ↓,
"highlight2" >IL10↓,

4794- Lyco,    Anticancer Effect of Lycopene in Gastric Carcinogenesis
- Review, GC, NA
"highlight2" >*AntiCan↑, Lycopene from red fruits and vegetables has strong anticancer activity in gastric carcinogenesis.
"highlight2" >*ROS↓, As one of the most potent antioxidants, lycopene is effective in decreasing oxidative damage by activating antioxidant enzymes such as GSH, GPx and GST.
"highlight2" >*GSH↑,
"highlight2" >*GPx↑,
"highlight2" >*GSTs↑,
"highlight2" >TumCG↓, Lycopene treatment inhibits cancer cell growth and induces apoptosis by suppressing ERK signaling pathway.
"highlight2" >Apoptosis↑,
"highlight2" >ERK↓,
"highlight2" >Bcl-2↓, Lycopene decreases Bcl-2 and increases Bax expression, which induce release of cytochrome C from mitochondria, leading to apoptosis.
"highlight2" >BAX↑,
"highlight2" >Cyt‑c↑,
"highlight2" >TumCCA↑, Lycopene treatment inhibits gastric cancer cell proliferation by increasing cell cycle arrest in G0–G1 phase
"highlight2" >*DNAdam↓, Lycopene inhibits H. pylori-induced increases in ROS levels and DNA damage in gastric epithelial cells

4803- Lyco,    Enhanced cytotoxic and apoptosis inducing activity of lycopene oxidation products in different cancer cell lines
- in-vitro, Pca, PC3 - in-vitro, BC, MCF-7 - in-vitro, Melanoma, A431 - in-vitro, Liver, HepG2 - in-vitro, Cerv, HeLa - in-vitro, Lung, A549
"highlight2" >tumCV↓, The decreased cell viability with depleted GSH and increased MDA levels were observed when treated with COL products than control, LYC and AOL
"highlight2" >GSH↓,
"highlight2" >MDA↑,
"highlight2" >ROS↑, In addition, COL products increased ROS levels and percent apoptosis.
"highlight2" >Apoptosis↑,

4802- Lyco,    Dietary intake of tomato and lycopene, blood levels of lycopene, and risk of total and specific cancers in adults: a systematic review and dose–response meta-analysis of prospective cohort studies
- Review, Var, NA
"highlight2" >Risk↓, In this systematic review and meta-analysis, we found that higher levels of dietary and blood lycopene were, respectively, associated with 5 and 11% lower risk of overall cancer. I

4801- Lyco,    Lycopene in the Prevention of Cardiovascular Diseases
- Review, CardioV, NA
"highlight2" >*BioAv↝, Taking into account the fact that humans are not able to synthesize lycopene de novo, therefore its supply with food is necessary to take advantage of its pro-health properties.
"highlight2" >*cardioP↑, protective effect on cardiovascular diseases
"highlight2" >*BioAv↑, It is assumed that thanks to the cis form, lycopene is highly bioavailable in the human diet
"highlight2" >*BioAv↑, bioavailability of lycopene as a result of its trans to cis isomerization can be achieved by adding fish oil or olive oil to tomato dishes.
"highlight2" >*antiOx↑, Antioxidant Effects of Lycopene
"highlight2" >*ROS↓, Lycopene is a highly effective antioxidant that, due to the high reactivity between the long polyene chain and free radicals, enables the elimination of singlet oxygen and the reduction of reactive oxygen species (ROS)
"highlight2" >*ARE↑, activating the antioxidant response element (ARE)
"highlight2" >*SOD↑, it increases the amount of antioxidant enzymes, which include superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px)
"highlight2" >*Catalase↑,
"highlight2" >*GPx↑,
"highlight2" >*lipid-P↓, figure 3
"highlight2" >*COX2↓, lycopene (in the form of watermelon powder) reduced inflammation by reducing the activity of the pro-inflammatory mediator cyclooxygenase 2 (COX-2),
"highlight2" >*Inflam↓, Anti-Inflammatory Mechanism of Lycopene
"highlight2" >*IL1β↓, inhibits the synthesis and release of pro-inflammatory cytokines, including IL-1β, IL-6, IL-8, and TNF-α.
"highlight2" >*IL6↓,
"highlight2" >*IL8↑,
"highlight2" >*TNF-α↓,
"highlight2" >*NF-kB↓, inhibition of the nuclear factor κB (NF-κB)
"highlight2" >*BP↓, 15 or 30 mg of lycopene was associated with a significant reduction in systolic BP

4800- Lyco,    Recent insights on pharmacological potential of lycopene and its nanoformulations: an emerging paradigm towards improvement of human health
- Review, Var, NA
"highlight2" >*antiOx↑, It is a potent antioxidant and free radical scavenger owing to the presence of 13 carbon–carbon double bonds, out of which 11 are conjugated and the remaining 2 are non-conjugated.
"highlight2" >Keap1↝, many biological effects on different types of cancers like prostate, breast, skin, and oral cancer by targeting the Keap1-NF-kB, Keap1-Nrf 2 and PI3K/AKT/m-TOR signalling pathway.
"highlight2" >NF-kB↝,
"highlight2" >NRF2↝,
"highlight2" >PI3K↝,
"highlight2" >Akt↝,
"highlight2" >mTOR↝,
"highlight2" >*GutMicro↑, lycopene also has the ability to modify the gut microbiome

4799- Lyco,    Anticancer Properties of Lycopene
- Review, Var, NA
"highlight2" >Risk↓, Dietary lycopene supplementation may reduce the risk of cancers of many organs such as prostate and at the same time retard the growth of tumors.
"highlight2" >TumCG↓,
"highlight2" >*antiOx↑, main protection properties of lycopene against cancer include antioxidant, anti-inflammatory, anti-inhibitory of cancer cell proliferation
"highlight2" >*Inflam↓,
"highlight2" >TumCP↓,
"highlight2" >TumCCA↑, , and cell cycle progression

4798- Lyco,    Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of Clinical and Preclinical Evidence
- Review, Var, NA
"highlight2" >AntiCan↑, Beyond its direct anticancer effects, LYP has been shown to enhance the efficacy of various anticancer agents when used in combination.
"highlight2" >ChemoSen↑,
"highlight2" >eff↑, LYP, when used in combination with other therapeutic agents, can modulate several key oncogenic signaling pathways, including JAK2, MAPK, Akt/mTOR, IGF-1R, Akt/EZH2/AR, and PPARγ/LXRα/ABCA1.
"highlight2" >eff↑, alterations have been observed when LYP is combined with various anticancer therapeutics, including radiation therapy, photodynamic therapy, standard chemotherapeutic agents such as cisplatin, 5-fluorouracil, taxanes, and sorafenib

4797- Lyco,    A mechanistic updated overview on lycopene as potential anticancer agent
- Review, Var, NA
"highlight2" >AntiCan↑, The anticancer potential of lycopene has been described by various in vitro cells, animal studies, and some clinical trials.
"highlight2" >antiOx↓, anticancer potential of lycopene is mainly due to its powerful singlet-oxygen quencher characteristics, simulation of detoxifying/antioxidant enzymes production,
"highlight2" >Apoptosis↓, initiation of apoptosis, inhibition of cell proliferation and cell cycle progression as well as modulations of gap junctional communication, the growth factors, and signal transduction pathways
"highlight2" >TumCP↓,
"highlight2" >TumCCA↑,
"highlight2" >Risk↓, The link between increased lycopene consumption and reducedoccurrence of a variety of cancers has been documented by in vitro cells,animal studies, and some clinical studies.
"highlight2" >ROS↓, The antioxidant action of lycopene toward ROS
"highlight2" >SOD↑, Lycopene can simulate detoxifying/antioxidant enzyme productionsuch as superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), and glutathione reductase.
"highlight2" >Catalase↑, . By stimulating ARE system, the lycopene can increase detoxifying/antioxidant enzymes production such as SOD, CAT, GST
"highlight2" >GSTs↑,
"highlight2" >ARE↑, The upregulating of the ARE system by lycopere has been studied in human BEAS-2B, HepG2, and MCF7
"highlight2" >NRF2↑, figure 1
"highlight2" >cycD1↓, figure 2
"highlight2" >cycE↑,
"highlight2" >CDK2↑,
"highlight2" >p27↑,
"highlight2" >BAX↑,
"highlight2" >Bcl-2↓,
"highlight2" >P53↑,
"highlight2" >ChemoSen↑, Lycopene has also been declared to have a synergistic effect with drugs used in cancer treatment [16,17,27,32]. Lycopene may contribute to improved anticancer effects of enzalutamide

4796- Lyco,    The Anti-proliferation Effects of Lycopene on Breast Cancer Cells
- in-vitro, BC, MCF-7 - in-vitro, Nor, MCF10
"highlight2" >TumCG↓, increasing concentrations of lycopene had a significant inhibitory effect only on MCF-7 cells
"highlight2" >selectivity↑, The two cell lines responded differently to lycopene treatment,
"highlight2" >*BioAv↑, The absorption of lycopene into the mucosal cells requires bile acid micelles that are aided by ingesting meals that include dietary fat
"highlight2" >*antiOx↑, Lycopene acts as a powerful antioxidant in protecting cells against oxidative damage and loss of normal cell function
"highlight2" >*ROS↓, figure 3
"highlight2" >Risk↓, Many of the studies that have been done so far with lycopene have looked at its role in prostate cancer, and one study reports a 35% risk reduction of prostate cancer with 10 weekly servings of tomato
"highlight2" >*cardioP↑,

4795- Lyco,    Updates on the Anticancer Profile of Lycopene and its Probable Mechanism against Breast and Gynecological Cancer
- Review, BC, NA
"highlight2" >TumCG↓, Experimental studies suggest that lycopene can inhibit tumor growth by regulating various signaling pathways for cell growth, arresting the cell cycle, and inducing cell apoptosis.
"highlight2" >TumCCA↑,
"highlight2" >Apoptosis↑,
"highlight2" >P53↝, Lycopene is reported to combat breast cancer specifically via mechanisms, such as regulation of expression of p53 and Bax, suppression of cyclin D
"highlight2" >BAX↝,
"highlight2" >cycD1↓,
"highlight2" >ERK↓, inhibiting the activation of ERK and Akt signaling pathway,
"highlight2" >Akt↓,
"highlight2" >STAT3↓, and gynecological cancer via various signaling pathways such as STAT3, Nrf2, and NF-κB, down-regulation of ITGB1, ITGA5, FAK, MMP9, and EMT markers, etc.
"highlight2" >NRF2↝,
"highlight2" >NF-kB↓,
"highlight2" >ITGB1↓,
"highlight2" >ITGA5↓,
"highlight2" >FAK↓,
"highlight2" >MMP9↓,
"highlight2" >EMT↓,

4783- Lyco,    Lycopene suppresses gastric cancer cell growth without affecting normal gastric epithelial cells
- in-vitro, GC, AGS - in-vitro, GC, SGC-7901 - in-vitro, Nor, GES-1
"highlight2" >TumCG↓, Lycopene specifically suppressed cell growth monitored by Real-Time Cell Analyzer, induced cell cycle arrest and cell apoptosis detected by flow cytometry, and lowered mitochondrial membrane potentials assessed by JC-1 staining of AGS and SGC-7901 ce
"highlight2" >TumCCA↑,
"highlight2" >Apoptosis↑,
"highlight2" >MMP↓,
"highlight2" >selectivity↑, while did not affect those of GES-1 cells.
"highlight2" >cycE1↓, Lycopene decreased the high expression levels of CCNE1 and increased the levels of TP53 in AGS and SGC-7901 cells without affecting those in GES-1 cells.
"highlight2" >TP53↑,
"highlight2" >*antiOx↑, Lycopene has a strong antioxidant property without pro-Vitamin A function

4793- Lyco,    Lycopene treatment inhibits activation of Jak1/Stat3 and Wnt/β-catenin signaling and attenuates hyperproliferation in gastric epithelial cells
- in-vitro, GC, AGS
"highlight2" >antiOx↑, Lycopene is a potent antioxidant exhibiting anticancer effects.
"highlight2" >AntiCan↑,
"highlight2" >ROS↓, results show that lycopene reduced ROS levels and inhibited Jak1/Stat3 activation, alteration of Wnt/β-catenin multiprotein complex molecules, expression of c-Myc and cyclin E, and cell proliferation in H pylori–infected AGS cells.
"highlight2" >JAK1↓,
"highlight2" >STAT3↓,
"highlight2" >Wnt↓,
"highlight2" >β-catenin/ZEB1↓,
"highlight2" >cMyc↓,
"highlight2" >cycE↓,
"highlight2" >TumCP↓,
"highlight2" >Risk↓, Lycopene might be a potential and promising nutrient for preventing H pylori–associated gastric diseases including gastric cancer.

4792- Lyco,    A Comprehensive Review on the Molecular Mechanism of Lycopene in Cancer Therapy
- Review, Var, NA
"highlight2" >*AntiCan↑, The antioxidant profile of lycopene promotes anticancerous properties that reduce cancer prevalence by activating cell signaling pathways and gene expression (involved in cancer cell proliferation).
"highlight2" >*antiOx↑,
"highlight2" >Inflam↓, Lycopene's anti-inflammatory properties suppresses the tumor growth and development- promoting pathways, such as the PI3K/Akt/mTOR pathway.
"highlight2" >Wnt↓, anticancer property of lycopene is also evidenced by its inhibi- tory potential of the Wnt/β-catenin signaling pathway that is involved in cancer cell modulation and propagation.
"highlight2" >β-catenin/ZEB1↓,
"highlight2" >*ROS↓, Lycopene also suppresses and neutralizes oxidative stress and reactive oxygen species (ROS)-induced DNA damage, preventing gene mutation.
"highlight2" >BioAv↑, high-pressure homogenization having 80 MPa pressure and 25°C temperature (Carpentieri et al. 2023),and freeze-dried tomatoes (Tan et al. 2021) have improved the bioavailability and bioaccessibility of lycopene.
"highlight2" >ROS↓, ycopene against pancreatic acinar cells was determined, it was found that IL- 6 and NF-kB are suppressed by lycopene (2 or 5 μmol/L) after 2 h of cerulein activation, demonstrating their role in neutralizing ROS
"highlight2" >Risk↓, Mia et al. (2023) determined prostate cancer-lowering properties of lycopene among 47,365 individuals.
"highlight2" >PGE2↓, Lycopene also exhibited its suppressive effect by reducing PGE2, COX-2, and phosphorylated ERK1/2 protein (Marino et al. 2023).
"highlight2" >COX2↓,
"highlight2" >p‑ERK↓,
"highlight2" >P21↑, lycopene and fish oil supplementation was revealed by the elevated expression of cell cycle inhibitors (p21 CIP1/WAF1 and p27Kip1) as well as by the reduced expression of MMP-7, MMP-9, COX-2, PGE2
"highlight2" >MMP7↓,
"highlight2" >MMP9↓,
"highlight2" >ChemoSen↑, It was observed that lycopene and cisplatin act synergistically to arrest cell growth by enhancing Bax & Nrf2 expression and inactivating Bcl-2 and NF-kB pathways
"highlight2" >eff↑, lycopene silver nanoparticles (LyAgNP) suppressed the progression of HeLa cells and COLO320DM cells

4791- Lyco,    Investigating into anti-cancer potential of lycopene: Molecular targets
- Review, Var, NA
"highlight2" >*antiOx↑, Lycopene, the main pigment of tomatoes, possess the strongest antioxidant activity among carotenoids. Lycopene has unique structure and chemical properties.
"highlight2" >TumCP↓, the anticancer of lycopene is also considered to be an important determinant of tumor development including the inhibition of cell proliferation, inhibition of cell cycle progression, induction of apoptosis, inhibition of cell invasion, angiogenesis
"highlight2" >TumCCA↓,
"highlight2" >Apoptosis↑,
"highlight2" >TumCI↓,
"highlight2" >angioG↓,
"highlight2" >TumMeta↓,
"highlight2" >*Risk↓, and may be associated with a decreased risk of different types of cancer.
"highlight2" >cycD1↓, Several studies suggested lycopene decreased cell cycle related proteins, such as cyclin D1, D3 and E, the cyclin-dependent kinases 2 and 4, bcl-2, while decreased phospho-Akt levels and increased p21, p27, p53 and bax levels and in Bax: Bcl-2 ratio
"highlight2" >CycD3↓,
"highlight2" >cycE↓,
"highlight2" >CDK2↓,
"highlight2" >CDK4↓,
"highlight2" >Bcl-2↓,
"highlight2" >P21↑,
"highlight2" >p27↑,
"highlight2" >P53↑,
"highlight2" >BAX↑,
"highlight2" >selectivity↑, lycopene selectively inhibited cell growth in MCF-7 human breast cancer cells but not in the MCF-10 mammary epithelial cells
"highlight2" >MMP↓, When treating LNCaP human prostate cancer cells with lycopene, the decreased mitochondrial function could be observed.
"highlight2" >Cyt‑c↑, release of mitochondrial cytochrome c and finally led to apoptosis
"highlight2" >Wnt↓, Lycopene could inhibit Wnt-TCF signaling pathway in cancer cells.
"highlight2" >eff↑, Lycopene could synergistically increase QC anticancer activity and inhibit Wnt-TCF signaling in cancer cells.
"highlight2" >PPARγ↑, Lycopene could inhibit the growth of cancer cells by activating the PPARγ – LXRα - ABCA1 pathway and decreasing cellular total cholesterol levels
"highlight2" >LDL↓,
"highlight2" >Akt↓, Lycopene suppressed Akt activation and non-phosphorylated β-Catenin,
"highlight2" >PI3K↓, inhibited the proliferation of colon cancer HT-29 cells, which was associated with suppressing PI3K/Akt/mTOR signaling pathway
"highlight2" >mTOR↓,
"highlight2" >PDGF↓, Lycopene, however, could inhibit PDGF-BB-induced signaling and cell migration in both human cultured skin fibroblasts and melanoma-derived fibroblasts
"highlight2" >NF-kB↓, anticancer properties of lycopene may occur to play its role through the inhibition of the NF-κB signaling pathway
"highlight2" >eff↑, lycopene increased the sensitization of cervical cancer cells to cisplatin via the suppression of NF-κB-mediated inflammatory responses, and the modulation of Nrf2-mediated oxidative stress

4790- Lyco,    Role of Lycopene in the Control of ROS-Mediated Cell Growth: Implications in Cancer Prevention
- Review, Var, NA
"highlight2" >*antiOx↑, t has also been suggested that lycopene might act as an antioxidant by repairing vitamin E and vitamin C radicals
"highlight2" >*ROS⇅, It is hypothesized that lycopene can behave as an antioxidant at low concentrations and as a prooxidant at high concentrations.
"highlight2" >TumCP↓, n vitro study, the treatment of androgen-independent prostate cancer cells (PC-3) with various concentrations of lycopene (20, 40 and 60 μM) showed a significant decrease in cell proliferation
"highlight2" >AP-1↓, It has been reported that lycopene is able to inhibit AP-1 signalling in mammary cancer cells
"highlight2" >eff↓, prostate cancer cell lines, lycopene alone (at physiological concentrations of 1 μM) was without much effect, but in combination with -tocopherol at 50 μM, it exhibited a synergistic effect

4789- Lyco,    Inhibitory Effect of Lycopene on Amyloid-β-Induced Apoptosis in Neuronal Cells
- in-vitro, AD, SH-SY5Y
"highlight2" >*antiOx↑, Lycopene is an antioxidant protecting from oxidative stress-induced cell damage
"highlight2" >*ROS↓, Lycopene inhibited apoptosis by reducing ROS, and by inhibiting mitochondrial dysfunction and NF-κB-target gene Nucling expression in neuronal cells.
"highlight2" >*NF-kB↓,
"highlight2" >*neuroP↑, Lycopene may be beneficial for preventing oxidative stress-mediated neuronal death in patients with neurodegeneration.
"highlight2" >*MMP↓, As shown in Figure 3C, amyloid-β increased the ratio of green to red fluorescence in the cells, which reflects a decrease in MMP in amyloid β-stimulated cells
"highlight2" >*mtDam↓, Lycopene suppressed decrease in OCR in amyloid-β-stimulated cell, suggesting that lycopene prevents mitochondrial damage induced by amyloid-β in the cells.
"highlight2" >*OCR↓, In the present study, lycopene significantly inhibited amyloid-β-induced mitochondrial dysfunction, which was proven by its protective effect in reducing both MMP and OCR.

4788- Lyco,    Lycopene as a potential anticancer agent: Current evidence on synergism, drug delivery systems and epidemiology (Review)
- Review, Var, NA
"highlight2" >AntiCan↑, It may be associated with a reduction in the morbidity and mortality of several types of cancer, making it a prom‑ ising anticancer agent
"highlight2" >ChemoSen↑, present review summarizes the synergistic effects of lycopene as a dietary supplement with other chemotherapy drugs or nutrients, for the enhancement of anticancer effects or the reduction of side effects from chemotherapy drugs.
"highlight2" >chemoP↑,
"highlight2" >Dose↝, Shao and Hathcock (20) proposed a 75 mg/day intake as the upper limit of lycopene for supplements, as no adverse effects were reported from continuous administration of 75 mg/day lycopene in a 4‑week clinical study
"highlight2" >BioAv↑, Thermal processing of tomato products can cause changes in the structure of lycopene to shift and yield cis‑isomers in the product and this form is more bioavailable
"highlight2" >BioAv↑, The presence of fat in food also helps enhance the absorption of lycopene (40) and its absorption is influenced by the amount of ingested fat, and the type and emulsification of dietary fat
"highlight2" >BioAv↓, avoid the consumption of lycopene concurrently with high dietary fiber, as several types of dietary fiber (e.g. pectin, guar, alginate, etc.) are associated with lower bioavailability of lycopene
"highlight2" >cardioP↑, figure 2
"highlight2" >AntiDiabetic↑,
"highlight2" >hepatoP↑,
"highlight2" >neuroP↑,
"highlight2" >MAPK↓, 2 mg/kg; 5 mg/kg Inhibition of MAPK signaling pathway (48) and decreased MMP‑2 and MMP‑9 activities through the activation of NM23‑H1, TIMP‑1 and TIMP‑2 expression.
"highlight2" >MMP2↓,
"highlight2" >MMP9↓,
"highlight2" >TIMP1↑,
"highlight2" >TIMP2↑,

4786- Lyco,    Anti-proliferative and apoptosis-inducing activity of lycopene against three subtypes of human breast cancer cell lines
- in-vitro, BC, MDA-MB-468 - in-vitro, BC, MCF-7 - in-vitro, BC, SkBr3
"highlight2" >TumCP↓, dose-dependent anti-proliferative activity against these cell lines by arresting the cell cycle at the G0/G1 phase at physiologically achievable concentrations found in human plasma.
"highlight2" >TumCCA↑,
"highlight2" >cl‑PARP↑, demonstrable cleavage of PARP.
"highlight2" >ERK↑, Lycopene induced strong and sustained activation of the ERK1/2, with concomitant cyclin D1 suppression and p21 upregulation in these three cell lines
"highlight2" >cycD1↓,
"highlight2" >P21↓,
"highlight2" >p‑Akt↓, lycopene inhibited the phosphorylation of Akt and its downstream molecule mTOR, followed by subsequent upregulation of proapoptotic Bax
"highlight2" >mTOR↓,
"highlight2" >BAX↑,
"highlight2" >AntiCan↑, data indicate that the predominant anticancer activity of lycopene in MDA-MB-468 cells
"highlight2" >Risk↓, Lycopene has been shown to reduce the risk of overall breast cancer more prominently than other carotenoids

4785- Lyco,    The Protective Anticancer Effect of Natural Lycopene Supercritical CO2 Watermelon Extracts in Adenocarcinoma Lung Cancer Cells
- in-vitro, Lung, A549
"highlight2" >ROS↑, we found that Lyc W significantly increased the spontaneous release of ROS
"highlight2" >NF-kB↑, We found that Lyc W significantly increased the nuclear expression of NF-kB in comparison to medium (p = 0.0289) and to Lyc G, Lyc T and Lyc S treatments
"highlight2" >Apoptosis↑, Lyc W Induces Cell Apoptosis

3528- Lyco,    The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene
- Review, Nor, NA - Review, AD, NA - Review, Park, NA
"highlight2" >*antiOx↑, the antioxidant effect of lycopene
"highlight2" >*ROS↓, Lycopene has the ability to reduce reactive oxygen species (ROS) and eliminate singlet oxygen, nitrogen dioxide, hydroxyl radicals, and hydrogen peroxide
"highlight2" >*BioAv↝, human body cannot synthesize lycopene. It must be supplied with the diet
"highlight2" >*Half-Life↑, half-life of lycopene in human plasma is 12–33 days
"highlight2" >*BioAv↓, bioavailability decreases with age and in the case of certain diseases
"highlight2" >*BioAv↑, heat treatment process of food increases the bioavailability of lycopene
"highlight2" >*cardioP↑, positive effect on cardiovascular diseases, including the regulation of blood lipid levels
"highlight2" >*neuroP↑, beneficial effects in nervous system disorders, including neurodegenerative diseases such as Parkinson′s disease and Alzheimer′s disease
"highlight2" >*H2O2↓, Lycopene has the ability to reduce reactive oxygen species (ROS) and eliminate singlet oxygen, nitrogen dioxide, hydroxyl radicals, and hydrogen peroxide
"highlight2" >*VitC↑, ability to regenerate non-enzymatic antioxidants such as vitamin C and E.
"highlight2" >*VitE↑,
"highlight2" >*GPx↑, increase in cardiac GSH-Px activity and an increase in cardiac GSH levels
"highlight2" >*GSH↑,
"highlight2" >*MPO↓, also a decrease in the level of cardiac myeloperoxidase (MPO), cardiac H2O2, and a decrease in cardiac glutathione S transferase (GSH-ST) activity.
"highlight2" >*GSTs↓,
"highlight2" >*SOD↑, increasing the activity of GSH-Px and SOD in the liver
"highlight2" >*NF-kB↓, reducing the expression of NF-κB mRNA in the heart
"highlight2" >*IL1β↓, decreased the level of IL-1β and IL-6 and increased the level of anti-inflammatory IL-10 in the heart
"highlight2" >*IL6↓,
"highlight2" >*IL10↑,
"highlight2" >*MAPK↓, inhibited the activation of the ROS-dependent pro-hypertrophic mitogen-activated protein kinase (MAPK) and protein kinase B (Akt) signaling pathways.
"highlight2" >*Akt↓,
"highlight2" >*COX2↓, decrease in the levels of pro-inflammatory mediators in heart: COX-2, TNF-α, IL-6, and IL-1β and an increase in the anti-inflammatory cardiac TGF-β1.
"highlight2" >*TNF-α↓,
"highlight2" >*TGF-β1↑,
"highlight2" >*NO↓, reduced NO levels in heart and cardiac NOS activity
"highlight2" >*GSR↑, increase in the level of cardiac and hepatic SOD, CAT, GSH, GPx, and glutathione reductase (GR)
"highlight2" >*NRF2↑, It also activated nuclear factor-erythroid 2 related factor 2 (Nrf2). This affected the downstream expression of HO-1 [97].
"highlight2" >*HO-1↑,
"highlight2" >*TAC↑, Researchers observed an increase in the liver in TAC and GSH levels and an increase in GSH-Px and SOD activity
"highlight2" >*Inflam↓, study showed that lycopene was anti-inflammatory
"highlight2" >*BBB↑, Lycopene is a lipophilic compound, which makes it easier to penetrate the blood–brain barrier.
"highlight2" >*neuroP↑, Lycopene had also a neuroprotective effect by restoring the balance of the NF-κB/Nrf2 pathway.
"highlight2" >*memory↑, lycopene on LPS-induced neuroinflammation and oxidative stress in C57BL/6J mice. The tested carotenoid prevented memory loss

1714- Lyco,    Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load
- in-vitro, Ovarian, OV-MZ-6 - in-vivo, NA, NA
"highlight2" >ChemoSen↑, Lycopene treatment synergistically enhanced anti-tumorigenic effects of paclitaxel and carboplatin
"highlight2" >CA125↓, Lycopene decreased the expression of the ovarian cancer biomarker, CA125.
"highlight2" >ITGA5↓, down-regulated expression of ITGA5, ITGB1, MMP9, FAK, ILK and EMT markers, decreased protein expression of integrin α5 and reduced activation of MAPK.
"highlight2" >ITGB1↓,
"highlight2" >MMP9↓,
"highlight2" >FAK↓,
"highlight2" >EMT↓,
"highlight2" >MAPK↓,
"highlight2" >MMP9↓, Levels of MMP9 in serum and ascites were reduced upon lycopene prevention
"highlight2" >antiOx↑, The antioxidant properties of lycopene have been reported for the prevention and treatment of different tumor entities, especially in prostate cancer
"highlight2" >Ki-67↓, expression of Ki67 in tumor tissues was lowered upon lycopene treatment compared to the placebo
"highlight2" >MAPK↓, reduced the protein expression of integrin α5 and activation of MAPK signaling

3261- Lyco,    Lycopene and Vascular Health
- Review, Stroke, NA
"highlight2" >*Inflam↓, main activity profile of lycopene includes antiatherosclerotic, antioxidant, anti-inflammatory, antihypertensive, antiplatelet, anti-apoptotic, and protective endothelial effects, the ability to improve the metabolic profile, and reduce arterial stif
"highlight2" >*antiOx↑, It is a much more potent antioxidant than alpha-tocopherol (10 × more potent) or beta-carotene (twice as potent)
"highlight2" >*AntiAg↑, lycopene, protecting against myocardial infarction and stroke, is its antiplatelet activity
"highlight2" >*cardioP↑, favorable effect in patients with subclinical atherosclerosis, metabolic syndrome, hypertension, peripheral vascular disease, stroke and several other cardiovascular disorders
"highlight2" >*SOD↑, Lycopene modulates also the production of antioxidant enzymes, such as superoxide dismutase and catalase
"highlight2" >*Catalase↑,
"highlight2" >*ROS↓, By reducing oxidative stress and reactive oxygen species, lycopene increases the bioavailability of nitric oxide (NO), improves endothelium-dependent vasodilation and reduces protein, lipids, DNA, and mitochondrial damage (
"highlight2" >*mtDam↓,
"highlight2" >*cardioP↑, Lycopene exerts a cardioprotective effect against atrazine induced cardiac injury due to its anti-inflammatory effect, by blocking the NF-kappa B pathway and NO production
"highlight2" >*NF-kB↓,
"highlight2" >*NO↓,
"highlight2" >*COX2↓, downregulation of cyclooxygenase 2,
"highlight2" >*LDL↓, significant reductions in total and LDL cholesterol were revealed only at doses of, at least, 25 mg lycopene/day
"highlight2" >*eff↑, It was noticed that lycopene can potentiate the antiplatelet effect of aspirin, which requires low lycopene diet
"highlight2" >*ER Stress↓, Lycopene protects the cardiomyocytes by relieving ERS
"highlight2" >*BioAv↑, Lycopene is very bioavailable in the presence of oil, especially in monounsaturated oils, other dietary fats and processed tomato products
"highlight2" >*eff↑, Lycopene can increase the antioxidant properties of vitamin C, E, polyphenols and beta-carotene in a synergistic way
"highlight2" >*MMPs↓, figure 3, secretion of MMPs
"highlight2" >*COX2↓,
"highlight2" >*RAGE↓,

3260- Lyco,    Lycopene in human health
- Review, NA, NA
"highlight2" >*BioAv↝, Lycopene bioavailability is lower in raw sources than in thermal processed food sources.
"highlight2" >*BioAv↓, As a result of the low bioavailability of lycopene, its circulating levels are more suitable as prognostic data for health outcomes than its dietary intake values
"highlight2" >*ROS⇅, A beneficial or prejudicial cellular response by lycopene will depend on its antioxidant or prooxidant properties respectively, depending on the cellular and extracellular environment
"highlight2" >*BioAv↝, Thus, there is less bioavailability of lycopene in fresh tomatoes than in processed tomato products (such as pasteurized tomato juice, soup, sauce and ketchup)

1721- Lyco,  RES,  VitC,    Lycopene, resveratrol, vitamin C and FeSO4 increase damage produced by pro-oxidant carcinogen 4-nitroquinoline-1-oxide in Drosophila melanogaster: Xenobiotic metabolism implications.
- in-vitro, Pca, PC3 - in-vitro, Lung, A549 - in-vitro, Cerv, HeLa - in-vitro, BC, MCF-7 - in-vitro, Liver, HepG2
"highlight2" >ROS↑, We propose that the basal levels of the XM's enzymes in the ST cross interacted with a putative pro-oxidant activity of the compounds added to the pro-oxidant effects of 4-NQO.

1720- Lyco,    Antioxidant and Pro-oxidant Activities of Carotenoids
- Review, Nor, NA
"highlight2" >ROS↑, lycopene (50 μM) exhibited pro-oxidant effects in in vitro cellular assays with several cancer cell lines (PC-3), (A549), (HeLa), (MCF-7), (A431), and (HepG2)

1719- Lyco,    Lycopene for the prevention and treatment of prostate disease.
- Review, Var, NA
"highlight2" >ROS⇅, Lycopene, a member of the carotenoid family, found commonly in red pigmented fruit and vegetables has been established as having strong antioxidant and pro-oxidant properties.

1718- Lyco,    The role of carotenoids in the prevention of human pathologies
- Review, Var, NA
"highlight2" >ROS⇅, Thus, in thymocytes, β-Carotene is an antioxidant at low oxygen pressure but a pro-oxidant at high oxygen concentrations
"highlight2" >ROS↑, lycopene may have also prooxidant activities depending on the type of oxidants used.

1717- Lyco,    Potential Role of Carotenoids as Antioxidants in Human Health and Disease
- Review, Var, NA
"highlight2" >antiOx↑, unique antioxidative properties.
"highlight2" >ROS⇅, The molecular mechanisms underlying these reactions are still not fully understood, especially in the context of the anti- and pro-oxidant activity of carotenoids
"highlight2" >ROS↑, antioxidant potential (e.g., lutein) or even leads to pro-oxidant behavior (i.e., zeaxanthin)

1716- Lyco,    Anti-inflammatory Activity of β-Carotene, Lycopene and Tri-n-butylborane, a Scavenger of Reactive Oxygen Species
- in-vitro, AML, RAW264.7
"highlight2" >antiOx↑, carotenoids β-carotene and lycopene are antioxidants that not only quench singlet oxygen but also inhibit lipid peroxidation
"highlight2" >lipid-P↓,
"highlight2" >ROS↑, These findings could explain the intriguing pro-oxidant and cytotoxic activity of β-carotene.
"highlight2" >Dose↑, new radical peaks then becoming slightly but reproducibly evident at concentrations over 10 mM

1715- Lyco,    Pro-oxidant Actions of Carotenoids in Triggering Apoptosis of Cancer Cells: A Review of Emerging Evidence
- Review, Var, NA
"highlight2" >antiOx↑, Carotenoids are well known for their potent antioxidant function in the cellular system.
"highlight2" >ROS↑, However, in cancer cells with an innately high level of intracellular reactive oxygen species (ROS), carotenoids may act as potent pro-oxidant molecules and trigger ROS-mediated apoptosis
"highlight2" >ChemoSen↑, when carotenoids are delivered with ROS-inducing cytotoxic drugs, they can minimize the adverse effects of these drugs on normal cells by acting as antioxidants without interfering with their cytotoxic effects on cancer cells as pro-oxidants
"highlight2" >selectivity↑, In cancer cells with innately high intracellular ROS levels, carotenoids may act as pro-oxidants and trigger ROS-mediated apoptosis of cancer cells.
"highlight2" >eff↓, However, under high oxygen tension conditions (e.g., in the lungs of smokers), β-carotene shows tumor-promoting effects.
"highlight2" >Casp3↑,
"highlight2" >Casp7↑,
"highlight2" >Casp9↑,
"highlight2" >P53↑,
"highlight2" >BAX↑,
"highlight2" >DNAdam↑,
"highlight2" >mtDam↑, mitochondrial dysfunction
"highlight2" >eff↑, Astaxanthin co-treatment with β-carotene and lutein (equimolar 5 µM each)

3262- Lyco,    Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1
- in-vitro, adrenal, SK-HEP-1
"highlight2" >TumCI↓, lycopene (1–10 μM) significantly inhibited SK-Hep-1 invasion (P<.05) and that this effect correlated with the inhibition of MMP-9 at the levels of enzyme activity
"highlight2" >MMP9↓,
"highlight2" >NF-kB↓, Lycopene also significantly inhibited the binding abilities of NF-κB and Sp1 and decreased, to some extent, the expression of insulin-like growth factor-1 receptor (IGF-1R) and the intracellular level of reactive oxygen species
"highlight2" >Sp1/3/4↓,
"highlight2" >IGF-1R↓,
"highlight2" >i-ROS↓,

1713- Lyco,    Lycopene: A Potent Antioxidant with Multiple Health Benefits
- Review, Nor, NA
"highlight2" >*antiOx↑, As one of the most potent antioxidants, its capacity to neutralise singlet oxygen is double that of ?-carotene, ten times greater than that of ?-tocopherol, and one hundred and twenty-five times more effective than glutathione
"highlight2" >*ROS⇅, lycopene acts as an antioxidant in systems that produce singlet oxygen but behaves as a pro-oxidant in systems that create peroxide
"highlight2" >*Dose↝, In low doses, it acts as an antioxidant, but at high doses, it acts as a pro-oxidant
"highlight2" >*eff↑, In situation where there is an imbalance between antioxidant defences and ROS production, such as during inflammation or exposure to environmental toxins [91], lycopene may switch from its antioxidant role to a pro-oxidant role
"highlight2" >*LDL↓, Wistar rats given a high-fat diet and 50mg/kg body weight of lycopene daily for 3mths had significant reductions in plasma total cholesterol, triglycerides, and lLDL levels but increased HDL cholesterol
"highlight2" >*RenoP↑, shown to protect the kidney against chemically induced damage
"highlight2" >*Inflam↓, evidence is plentiful demonstrating the anti-inflammatory effects of lycopene both in vitro and in vivo
"highlight2" >neuroP↑, mice with Alzheimer's disease induced by ? amyloid, lycopene reduced oxidative stress, decreased neuronal loss, improved synaptic plasticity, and inhibited neuroinflammation
"highlight2" >Rho↓, lycopene treatment was demonstrated to have the potential to mitigate vascular arteriosclerosis in allograft transplantation by inhibiting Rho-associated kinases

1712- Lyco,    Lycopene Protects against Smoking-Induced Lung Cancer by Inducing Base Excision Repair
- in-vitro, Lung, A549
"highlight2" >ROS↓, Conclusions: Lycopene treatment at a lower dosage could inhibit smoke-induced oxidative stress and promote genome stability
"highlight2" >ROS↑, we found that lycopene only exerted antioxidative effects at low-dosage, while such beneficial effects were diminished at high-dosage
"highlight2" >eff↑, suggesting an increased carotenoid uptake in the cells under oxidative stress

1711- Lyco,    Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review
- Review, Var, NA
"highlight2" >ROS↑, exposure to high doses of carotenoids has a pro-oxidant effect
"highlight2" >Dose↓, lycopene, an intake of 5 to 7 mg per day was recommended for healthy people to maintain the circulating levels of this carotenoid, in order to combat oxidative stress and prevent chronic diseases
"highlight2" >Dose↑, higher concentrations of lycopene (35–75 mg/day) may be required when there is a disease, such as cancer and cardiovascular diseases.
"highlight2" >antiOx↑, main protective effect of lycopene is due to its antioxidant effect through the inactivation of ROS and the extinction of free radicals
"highlight2" >P450↓, significant decrease in cytochrome P450 2E1
"highlight2" >TNF-α↓, TNF-α, IL-1β, and IL-12) were also found
"highlight2" >IL1β↓,
"highlight2" >IL12↓,

1710- Lyco,    Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases
- Review, CardioV, NA
"highlight2" >antiOx↓, Lycopene is a potent antioxidant that fights ROS and, subsequently, complications.
"highlight2" >ROS↓,
"highlight2" >BP↓, It reduces blood pressure via inhibiting the angiotensin-converting enzyme and regulating nitrous oxide bioavailability.
"highlight2" >LDL↓, important role in lowering of LDL (low-density lipoproteins) and improving HDL (high-density lipoproteins) levels to minimize atherosclerosis
"highlight2" >*toxicity∅, Lycopene is a natural substance that may be used in high doses as a dietary supplement without causing harm to human health or physiology
"highlight2" >eff↑, Thermal food processing, particularly in the presence of cooking oils, causes lycopene to micellize and enhance its intestinal absorption rate by a factor of ten
"highlight2" >ROS↑, As a pro-oxidant, lycopene may have both good and negative impacts in biological systems, as well as influence the course of human illnesses.
"highlight2" >*Half-Life↑, Plasma lycopene has a half-life of 12–33 days in the human body
"highlight2" >*BioAv↓, Tomato lycopene is not easily absorbed since it is integrated into the nutritional matrix.
"highlight2" >*BioAv↑, Clinical research demonstrates that heat-processed tomato products absorb lycopene more quickly than raw sources, and that adding oil increases absorption
"highlight2" >*antiOx↑, Lycopene’s ability to protect against oxidative stress has been established

1709- Lyco,    Lycopene prevents carcinogen-induced cutaneous tumor by enhancing activation of the Nrf2 pathway through p62-triggered autophagic Keap1 degradation
- in-vitro, Nor, JB6
"highlight2" >*antiOx↑, Lycopene stimulated the activation of antioxidant enzymes and the translocation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) that predominantly maintained intracellular redox equilibrium
"highlight2" >*NRF2↑, Lycopene activated the Nrf2 pathway in the presence of carcinogens in vivo and in vitro
"highlight2" >*GSH/GSSG↓, Lycopene also rebalanced the GSH/GSSG ratio, partly representing the cellular redox condition commendably
"highlight2" >*Catalase↝, catalase (CAT), glutathione reductase (GR), superoxide dismutase (SOD), and glutathione peroxidase (GPx), lower activities of these enzymes were reversed by this compound
"highlight2" >*GR↝,
"highlight2" >*SOD↝,
"highlight2" >*GPx↝,
"highlight2" >*GSH↑, mRNA levels of GSH and these antioxidant substances were also up-regulated significantly by lycopene pretreatment
"highlight2" >*Keap1↓, Lycopene induced activation of Nrf2 by reducing Keap1 protein
"highlight2" >*p62↑, lycopene induced p62 binding to Keap1, so Keap1 degradation was mediated by p62

1708- Lyco,    The Anti-Cancer Activity of Lycopene: A Systematic Review of Human and Animal Studies
- Review, Var, NA
"highlight2" >OS↑, reduced prostate cancer-specific mortality in men at high risk for prostate cancer
"highlight2" >ChemoSen↑, improved the response to docetaxel chemotherapy in advanced castrate-resistant prostate cancer
"highlight2" >QoL↑, lycopene improved the quality of life, and provided relief from bone pain and control of lower urinary tract symptoms
"highlight2" >PSA∅, PSA stabilisation in prostate cancer
"highlight2" >eff↑, Lycopene co-supplementation with vitamin E also showed an improvement in the results of prostate cancer treatment
"highlight2" >AntiCan↑, lycopene intake showed a strong protective effect against stomach cancer, regardless of H. pylori status
"highlight2" >AntiCan↑, A lycopene-rich diet was shown to reduce the incidence of pancreatic cancer in humans by 31%
"highlight2" >angioG↓,
"highlight2" >VEGF↓,
"highlight2" >Hif1a↓,
"highlight2" >SOD↑,
"highlight2" >Catalase↑,
"highlight2" >GPx↑,
"highlight2" >GSH↑,
"highlight2" >GPx↑,
"highlight2" >GR↑,
"highlight2" >MDA↓,
"highlight2" >NRF2↑,
"highlight2" >HO-1↑,
"highlight2" >COX2↓,
"highlight2" >PGE2↓,
"highlight2" >NF-kB↓,
"highlight2" >IL4↑,
"highlight2" >IL10↑,
"highlight2" >IL6↓,
"highlight2" >TNF-α↓,
"highlight2" >PPARγ↑,
"highlight2" >TumCCA↑, G(0)/G(1) phase
"highlight2" >FOXO3↓,
"highlight2" >Casp3↑,
"highlight2" >IGF-1↓, breast cancer,crc
"highlight2" >p27↑,
"highlight2" >STAT3↓,
"highlight2" >CDK2↓,
"highlight2" >CDK4↓,
"highlight2" >P21↑,
"highlight2" >PCNA↓,
"highlight2" >MMP7↓,
"highlight2" >MMP9↓,

1126- Lyco,    Lycopene Inhibits Epithelial–Mesenchymal Transition and Promotes Apoptosis in Oral Cancer via PI3K/AKT/m-TOR Signal Pathway
- vitro+vivo, Oral, NA
"highlight2" >TumCP↓,
"highlight2" >TumCMig↓,
"highlight2" >TumCI↓,
"highlight2" >Apoptosis↑,
"highlight2" >EMT↓,
"highlight2" >PI3K↓,
"highlight2" >Akt↓,
"highlight2" >mTOR↓,
"highlight2" >E-cadherin↓,
"highlight2" >BAX↑,
"highlight2" >N-cadherin↓,
"highlight2" >p‑PI3K↓,
"highlight2" >p‑Akt↓,
"highlight2" >p‑mTOR↓,
"highlight2" >Bcl-2↓,

1041- Lyco,  immuno,    Lycopene improves the efficiency of anti-PD-1 therapy via activating IFN signaling of lung cancer cells
- in-vivo, Lung, NA
"highlight2" >TumVol↓, combined lycopene and anti-PD-1 reduced the tumor volume and weight compared to control treatment.
"highlight2" >TumW↓,
"highlight2" >eff↑, lycopene could assist anti-PD-1 to elevate the levels of interleukin (IL)-1 and interferon (IFN) γ while reduce the levels of IL-4 and IL-10
"highlight2" >IL1↑,
"highlight2" >IFN-γ↑,
"highlight2" >IL4↓,
"highlight2" >IL10↓,

1013- Lyco,    Lycopene induces apoptosis by inhibiting nuclear translocation of β-catenin in gastric cancer cells
- in-vitro, GC, AGS
"highlight2" >Apoptosis↑,
"highlight2" >DNAdam↑,
"highlight2" >Bax:Bcl2↑,
"highlight2" >ROS↓, AGS cells. The results showed that lycopene reduces the levels of ROS
"highlight2" >β-catenin/ZEB1↓,
"highlight2" >p‑GSK‐3β↓,
"highlight2" >APC↑,
"highlight2" >β-TRCP↑,
"highlight2" >cMyc↓,
"highlight2" >cycD1↓,

3275- Lyco,    Multifaceted Effects of Lycopene: A Boulevard to the Multitarget-Based Treatment for Cancer
- Review, Var, NA
"highlight2" >TumCCA↑, lycopene impedes the progress of the cell cycle from the G1 to the S phase, primarily by diminishing the cyclin D and cyclin E levels.
"highlight2" >cycD1↓,
"highlight2" >cycE↓,
"highlight2" >CDK2↓, causes a subsequent inactivation of CDK4 and CDK2 through a reduced phosphorylation of Rb
"highlight2" >CDK4↓,
"highlight2" >P21↑, lycopene elevates CDK inhibitor, p21, and p53 (tumor suppressor) levels
"highlight2" >P53↑,
"highlight2" >GSK‐3β↓, Finally, GSK3β, p21, p27, Bad, caspase 9, and p53 (via Mdm2) are inactivated
"highlight2" >p27↓,
"highlight2" >Akt↓, lycopene inhibits AKT (protein kinase B) and mTOR
"highlight2" >mTOR↓,
"highlight2" >ROS↓, ability of lycopene to minimize ROS formation and mitigate oxidative stress
"highlight2" >MMPs↓, lycopene may decrease the activity of metalloproteinases of the matrix and prevent SK-Hep1 cellular adhesion, invasion, and migration
"highlight2" >TumCI↓,
"highlight2" >TumCMig↓,
"highlight2" >NF-kB↓, well-documented that lycopene inhibits NF-kB binding activity
"highlight2" >*iNOS↓, They also claimed that the lycopene caused a decline in the LPS-induced protein and mRNA expression of iNOS,
"highlight2" >*COX2↓, Lycopene can therefore decrease the gene expression of iNOS and COX-2 as a non-toxic agent via controlling pro-inflammatory genes
"highlight2" >lipid-P↓, suppress gastric cancer by multimodal mechanisms of reduction in lipid peroxidation, elevation in the levels of antioxidants, and enhanced GSH
"highlight2" >GSH↑,
"highlight2" >NRF2↑, Reportedly, lycopene is known to “upregulate” this ARE system via Nrf2 in vitro (HepG2 and MCF-7 cells)

3286- Lyco,    Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation
- in-vitro, Nor, NA
"highlight2" >*AntiAg↑, We found that lycopene concentration-dependently (2–12 μmol/L) inhibited platelet aggregation in human platelets stimulated by agonists.

3285- Lyco,    Comparative evaluation of antiplatelet effect of lycopene with aspirin and the effect of their combination on platelet aggregation: An in vitro study
- in-vitro, Nor, NA
"highlight2" >*AntiAg↑, All the concentrations of lycopene (4–12 μmol/L) exhibited reduction in maximum platelet aggregation induced by aggregating agents ADP and collagen
"highlight2" >*eff↑, Four μmol/L of lycopene combined with 140 μmol/L and 70 μmol/L aspirin showed greater inhibition of platelets as compared to aspirin 140 μmol/L alone, against both ADP and collagen.

3281- Lyco,  Chemo,    Lycopene Supplementation for Patients Under Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Review, Var, NA
"highlight2" >eff↑, Our study shows that lycopene supplementation does not modify the main hallmarks of cancer, but it increases circulating lycopene concentration in patients under cancer therapy, which could have a positive impact on potential clinical and molecular o
"highlight2" >cardioP↑, A systematic review and meta-analysis reported that tomato and lycopene supplementation have positive effects on cardiovascular risk factors
"highlight2" >eff?, lycopene supplementation may have benefits in the oncology population during cancer treatment.
"highlight2" >PSA↓, Lycopene supplementation improved PSA levels in patients with an intermediate risk of cancer
"highlight2" >RenoP↑, Surprisingly, lycopene has been shown to improve renal makers of nephrotoxicity after cisplatin treatment

3280- Lyco,    Lycopene as A Carotenoid Provides Radioprotectant and Antioxidant Effects by Quenching Radiation-Induced Free Radical Singlet Oxygen: An Overview
- Review, Var, NA
"highlight2" >*radioP↑, Studies have designated lycopene to be an effective radio-protector with negligible side effects.
"highlight2" >*antiOx↑, Antioxidant and radioprotective effects of lycopene
"highlight2" >*lipid-P↓, Pretreatment of lycopene to ã-irradiated lymphocytes resulted in decreased lipid peroxidation and improved antioxidant status which prevented damage to the lymphocytes

3279- Lyco,    The role of lycopene and its derivatives in the regulation of transcription systems: implications for cancer prevention
- Review, Var, NA
"highlight2" >chemoP↑, molecular mechanisms whereby lycopene and other carotenoids may exert their chemoprotective effects

3278- Lyco,    Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells
- in-vitro, Colon, SW480
"highlight2" >TNF-α↓, In cells treated with lycopene and LPS, the mRNA expression of TNF-α, IL-1β, IL-6, iNOS, and COX-2 were decreased significantly in a dose-dependent manner
"highlight2" >IL1β↓,
"highlight2" >IL6↓,
"highlight2" >iNOS↓,
"highlight2" >COX2↓,
"highlight2" >PGE2↓, The concentrations of PGE2 and NO decreased according to the lycopene concentration
"highlight2" >NO↓,
"highlight2" >NF-kB↓, The protein expressions of NF-κB and JNK were decreased significantly according to lycopene concertation
"highlight2" >JNK↓,
"highlight2" >Inflam↓, Lycopene was found to have anti-inflammatory effects in a rat model
"highlight2" >MPO↓, decreased myeloperoxidase (MPO) activity, as a marker of inflammation,

3277- Lyco,    Recent trends and advances in the epidemiology, synergism, and delivery system of lycopene as an anti-cancer agent
- Review, Var, NA
"highlight2" >antiOx↑, lycopene provides a strong antioxidant activity that is 100 times more effective than α-tocopherol and more than double effective that of β-carotene
"highlight2" >TumCP↓, In vivo and in vitro experiments have demonstrated that lycopene at near physiological levels (0.5−2 μM) could inhibit cancer cell proliferation [[22], [23], [24]], induce apoptosis [[25], [26], [27]], and suppress metastasis [
"highlight2" >Apoptosis↑,
"highlight2" >TumMeta↑,
"highlight2" >ChemoSen↑, lycopene can increase the effect of anti-cancer drugs (including adriamycin, cisplatin, docetaxel and paclitaxel) on cancer cell growth and reduce tumour size
"highlight2" >BioAv↓, low water solubility and bioavailability of lycopene
"highlight2" >Dose↝, The concentration of lycopene in plasma (daily intake of 10 mg lycopene) is approximately 0.52−0.6 μM
"highlight2" >BioAv↓, significant decrease in lycopene bioavailability in the elderly
"highlight2" >BioAv↑, oils and fats favours the bioavailability of lycopene [80], while large molecules such as pectin can hinder the absorption of lycopene in the small intestine due to their action on lipids and bile salt molecules
"highlight2" >SOD↑, GC: 50−150 mg/kg BW/day ↑SOD, CAT, GPx ↑IL-2, IL-4, IL-10, TNF-α ↑IgA, IgG, IgM ↓IL-6
"highlight2" >Catalase↑,
"highlight2" >GPx↑,
"highlight2" >IL2↑, lycopene treatment significantly enhanced blood IL-2, IL-4, IL-10, TNF-α levels and reduced IL-6 level in a dose-dependent manner.
"highlight2" >IL4↑,
"highlight2" >IL1↑,
"highlight2" >TNF-α↑,
"highlight2" >GSH↑, GC: ↑GSH, GPx, GST, GR
"highlight2" >GPx↑,
"highlight2" >GSTA1↑,
"highlight2" >GSR↑,
"highlight2" >PPARγ↑, ↑GPx, SOD, MDA ↑PPARγ, caspase-3 ↓NF-κB, COX-2
"highlight2" >Casp3↑,
"highlight2" >NF-kB↓,
"highlight2" >COX2↓,
"highlight2" >Bcl-2↑, AGS cells Lycopene 5 μM ↑Bcl-2 ↓Bax, Bax/Bcl-2, p53 ↓Chk1, Chk2, γ-H2AX, DNA damage ↓ROS Phase arrest
"highlight2" >BAX↓,
"highlight2" >P53↓,
"highlight2" >CHK1↓,
"highlight2" >Chk2↓,
"highlight2" >γH2AX↓,
"highlight2" >DNAdam↓,
"highlight2" >ROS↓,
"highlight2" >P21↑, CRC: ↑p21 ↓PCNA, β-catenin ↓COX-2, PGE2, ERK1/2 phosphorylated
"highlight2" >PCNA↓,
"highlight2" >β-catenin/ZEB1↓,
"highlight2" >PGE2↓,
"highlight2" >ERK↓,
"highlight2" >cMyc↓, AGS cells: ↓Wnt-1, c-Myc, cyclin E ↓Jak1/Stat3, Wnt/β-catenin alteration ↓ROS
"highlight2" >cycE↓,
"highlight2" >JAK1↓,
"highlight2" >STAT3↓,
"highlight2" >SIRT1↑, Huh7: ↑SIRT1 ↓Cells growth ↑PARP cleavage ↓Cyclin D1, TNFα, IL-6, NF-κB, p65, STAT3, Akt activation ↓Tumour multiplicity, volume
"highlight2" >cl‑PARP↑,
"highlight2" >cycD1↓,
"highlight2" >TNF-α↓,
"highlight2" >IL6↓,
"highlight2" >p65↓,
"highlight2" >MMP2↓, SK-Hep1 human hepatoma cells Lycopene 5, 10 μM ↓MMP-2, MMP-9 ↓
"highlight2" >MMP9↓,
"highlight2" >Wnt↓, AGS cells Lycopene 0.5 μM, 1 μM ↓Wnt-1, c-Myc, cyclin E ↓Jak1/Stat3, Wnt/β-catenin alteration ↓ROS

3276- Lyco,    Lycopene modulates cellular proliferation, glycolysis and hepatic ultrastructure during hepatocellular carcinoma
- in-vivo, HCC, NA
"highlight2" >G6PD↓, Moreover, NDEA treatment caused a significant increase in liver G6PD activity in the NDEA group when compared to the control and LycT groups.
"highlight2" >PCNA↓, The LycT + NDEA group showed a significant decrease in mRNA expression of PCNA and Cyclin D1 when compared to the NDEA group
"highlight2" >cycD1↓,
"highlight2" >P21↑, A significant increase in the expression of p21 was observed in the LycT + NDEA group when compared to the contro
"highlight2" >Hif1a↓, Pre-treatment with LycT in NDEA-challenged mice resulted in a significant reduction in the expression of HIF-1α at week 24 when compared to the NDEA group
"highlight2" >Glycolysis↓, Moreover, significant reductions in the activities of glycolytic enzymes following LycT pre-treatment in NDEA-challenged mice were inversely related to HCC development.

3287- Lyco,    Recent technological strategies for enhancing the stability of lycopene in processing and production
- Review, NA, NA
"highlight2" >*eff↑, With tangerine tomato juice we observed a marked 8.5-fold increase in lycopene bioavailability compared to red tomato juice was about 8.5 times than that of red tomato juice

3274- Lyco,    Lycopene enhances the sensitivity of castration-resistant prostate cancer to enzalutamide through the AKT/EZH2/ androgen receptor signaling pathway
- in-vitro, Pca, 22Rv1 - in-vitro, Pca, C4-2B
"highlight2" >Akt↓, enhanced antitumor effects of enzalutamide by lycopene may be related to the reduction of AR protein levels through lycopene-mediated inhibition of AKT/EZH2 pathway,
"highlight2" >EZH2↓,

3273- Lyco,    Lycopene
- Review, Var, NA
"highlight2" >antiOx↑, lycopene supplementation is associated with strong antioxidant effects, it has the potential to interfere with chemotherapy and radiation therapy
"highlight2" >ChemoSen↓,
"highlight2" >RadioS↓,

3268- Lyco,    Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders
- Review, AD, NA
"highlight2" >*BioAv↓, Lycopene bioavailability can be decreased by ageing, and some of the pathological states, such as cardiovascular diseases (CVDs)
"highlight2" >*AntiCan↑, For instance, it has been shown that a higher dietary intake and circulating concentration of lycopene have protective effects against prostate cancer (PCa), in a dose-dependent way
"highlight2" >*ROCK1↓, It remarkably lessened the expression of ROCK1, Ki-67, ICAM-1 and ROCK2,
"highlight2" >*Ki-67↓,
"highlight2" >*ICAM-1↓,
"highlight2" >*cardioP↑, Lycopene is a cardioprotective nutraceutical.
"highlight2" >*antiOx↑, Lycopene is a well-known antioxidant.
"highlight2" >*NQO1↑, Furthermore, lycopene supplementation improves mRNA expressions of the NQO-1 and HO-1 as antioxidant enzymes.
"highlight2" >*HO-1↑,
"highlight2" >*TNF-α↓, downregulate inflammatory cytokines (i.e., TNF-α, and IL-1β) in the hippocampus of the mice.
"highlight2" >*IL22↓,
"highlight2" >*NRF2↑, Lycopene decreased neuronal oxidative damage by activating Nrf2, as well as by inactivating NF-κB translocation in H2O2-related SH-SY5Y cell model
"highlight2" >*NF-kB↓,
"highlight2" >*MDA↓, significantly reduced the malondialdehyde (MDA)
"highlight2" >*Catalase↑, Furthermore, it improved the catalase (CAT), superoxide dismutase (SOD), and GSH levels, and antioxidant capacity [109].
"highlight2" >*SOD↑,
"highlight2" >*GSH↑,
"highlight2" >*cognitive↑, Lycopene administration considerably improved cognitive defects, noticeably reduced MDA levels and elevated GSH-Px activity, and remarkably reduced tau
"highlight2" >*tau↓,
"highlight2" >*hepatoP↑, Lycopene was also found to be effective against hepatotoxicity by acting as an antioxidant, regulating total glutathione (tGSH) and CAT concentrations
"highlight2" >*MMP2↑, It also elevated MMP-2 down-regulation
"highlight2" >*AST↓, lowering the liver enzymes levels, like aspartate transaminase (AST), alanine transaminase (ALT), LDL, free fatty acid, and MDA.
"highlight2" >*ALAT↓,
"highlight2" >*P450↑, Moreover, tomato powder has been shown to have a protective agent against alcohol-induced hepatic injury by inducing cytochrome p450 2E1
"highlight2" >*DNAdam↓, lycopene decreased DNA damage
"highlight2" >*ROS↓, It has been revealed that they inhibited ROS production, protected antioxidant enzymes, and reversed hepatotoxicity in rats’ liver
"highlight2" >*neuroP↑, lycopene consumption relieved cognitive defects, age-related memory loss, neuronal damage, and synaptic dysfunction of the brain.
"highlight2" >*memory↑,
"highlight2" >*Ca+2↓, Lycopene suppressed the 4-AP-invoked release of glutamate and elevated intra-synaptosomal Ca2+ level.
"highlight2" >*Dose↝, an in vivo study revealed that lycopene (6.5 mg/day) was effective against cancer in men [147]. However, lycopene dose should be increased up to 10 mg/day, in the case of advanced PCa.
"highlight2" >*Dose↑, lycopene supplementation (15 mg/day, for 12 weeks) in an old aged population improved immune function through increasing natural killer cell activity by 28%
"highlight2" >*Dose↝, Finally, according to different epidemiological studies, daily lycopene intake can be suggested to be 2 to 20 mg per day
"highlight2" >*toxicity∅, A toxicological study on rats showed the no-observed-adverse-effect level at the highest examined dose (i.e., 1.0% in the diet)
"highlight2" >PGE2↓, Lycopene doses of 0, 10, 20, and 30 µM were used to treat human colorectal cancer cell. Prostaglandin E2 (PGE2), and NO levels declined after lycopene administration,
"highlight2" >CDK2↓, Treatment with lycopene reduced cell hyperproliferation induced by UVB and ultimately promoted apoptosis and reduced CDK2 and CDK4 complex in SKH-1 hairless mice
"highlight2" >CDK4↓,
"highlight2" >STAT3↓, lycopene reduced the STAT3 expression in ovarian tissues
"highlight2" >NOX↓, (SK-Hep-1) cells and indicated a substantial reduction in NOX activity. Moreover, it inhibits the protein expression of NOX4, NOX4 mRNA and ROS intracellular amounts
"highlight2" >NOX4↓,
"highlight2" >ROS↓,
"highlight2" >*SREBP1↓, Lycopene decreases the fatty acid synthase (FAS), sterol regulatory element-binding protein 1c (SREBP-1c), and Acetyl-CoA carboxylase (ACC1) expression in HFD mice.
"highlight2" >*FASN↓,
"highlight2" >*ACC↓,

3267- Lyco,    Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-Akt and ERK/p38 signaling pathways
- in-vitro, Nor, HUVECs
"highlight2" >*VEGF↓, highest dose used (400 μg/plug) completely inhibited the formation of vascular endothelial cells induced by vascular endothelial growth factor (VEGF).
"highlight2" >*MMP2↓, lycopene inhibited tube formation, invasion, and migration in HUVECs, and such actions were accompanied by reduced activities of matrix metalloproteinase-2, urokinase-type plasminogen activator, and protein expression of Rac1
"highlight2" >*uPA↓,
"highlight2" >*Rac1↑,
"highlight2" >*TIMP2↑, and by enhancing protein expression of tissue inhibitors of metalloproteinase-2 and plasminogen activator inhibitor-1.
"highlight2" >*p38↓, lycopene attenuated VEGF receptor-2 (VEGFR2)-mediated phosphorylation of extracellular signal-regulated kinase (ERK), p38, and Akt as well as protein expression of PI3K.
"highlight2" >*Akt↓,
"highlight2" >*angioG↓, anti-angiogenic effect of lycopene both in vitro and in vivo.

3266- Lyco,    Effects of lycopene on number and function of human peripheral blood endothelial progenitor cells cultivated with high glucose
- in-vitro, Nor, NA
"highlight2" >*p38↓, lycopene blocked phosphorylation of p38 MAPK in EPCs
"highlight2" >*MAPK↓,

3265- Lyco,    Lycopene inhibits pyroptosis of endothelial progenitor cells induced by ox-LDL through the AMPK/mTOR/NLRP3 pathway
- in-vitro, Nor, NA
"highlight2" >*AMPK↑, through the activation of AMPK, which led to the inhibition of mTOR phosphorylation and subsequent downregulation of the downstream NLRP3 inflammasome.
"highlight2" >*mTOR↓,
"highlight2" >*NLRP3↓,
"highlight2" >*Pyro↓, Suppression of pyroptosis in EPCs by lycopene

3264- Lyco,    Pharmacological potentials of lycopene against aging and aging‐related disorders: A review
- Review, Var, NA - Review, AD, NA - Review, Stroke, NA
"highlight2" >*antiOx↑, Anti‐oxidative mechanism of lycopene
"highlight2" >*ROS↓, Lycopene inhibits ROS generation and subsequent oxidative stress by inducing antioxidant enzymes (SOD, CAT, GSH, GSH‐Px, and GST) and limiting MDA level and lipid peroxidation (LPO).
"highlight2" >*SOD↑,
"highlight2" >*Catalase↑,
"highlight2" >*GSH↑,
"highlight2" >*GSTs↑,
"highlight2" >*MDA↓,
"highlight2" >*lipid-P↓,
"highlight2" >*NRF2↑, Lycopene also prevents ROS release by upregulating Nrf2‐mediated HO‐1 levels and inhibiting iNOS‐activated NO generation
"highlight2" >*HO-1↑,
"highlight2" >*iNOS↓,
"highlight2" >*NO↓,
"highlight2" >*TAC↑, upregulating total antioxidant capacity (TAC) and direct inhibition of 8‐OHdG, NOX4.
"highlight2" >*NOX4↓,
"highlight2" >*Inflam↓, Anti‐inflammatory mechanism of lycopene.
"highlight2" >*IL1↓, IL‐1, IL‐6, IL‐8, IL‐1β, and TNF‐α release.
"highlight2" >*IL6↓,
"highlight2" >*IL8↓,
"highlight2" >*IL1β↓,
"highlight2" >*TNF-α↓,
"highlight2" >*TLR2↓, prevents inflammation by inhibiting toll‐like receptors TLR2 and TLR4 and endothelial adhesion molecules VCAM1 and ICAM‐1.
"highlight2" >*TLR4↓,
"highlight2" >*VCAM-1↓,
"highlight2" >*ICAM-1↓,
"highlight2" >*STAT3↓, inhibiting STAT3, NF‐κB, ERK pathway, and IL‐6 and TNF‐α release.
"highlight2" >*NF-kB↓,
"highlight2" >*ERK↓,
"highlight2" >*BP↓, Another clinical study demonstrated that consumption of raw tomato (200 g/day) could prevent type 2 diabetes‐associated cardiovascular diseases by lowering systolic and diastolic blood pressure, upregulating ApoA1, and downregulating ApoB levels
"highlight2" >ROS↓, lycopene suppresses the metastasis of the SK‐HEP‐1 cell line by NOX‐4 mRNA expression inhibition and the reactive ROS intracellular activity inhibition
"highlight2" >PGE2↓, Lycopene is also used to treat colorectal cancer cells in humans, and the introduction of lycopene decreases the prostaglandin E2 and nitric oxide levels
"highlight2" >cardioP↑, Lycopene‐rich foods can be highly beneficial in preventing cardiovascular diseases as lycopene is a potential source of antioxidants
"highlight2" >*neuroP↑, beneficial role of lycopene on aging‐related neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, has been confirmed in both experimental and clinical trials
"highlight2" >*creat↓, Several pre‐clinical studies reported that lycopene treatment significantly reduced serum urea and serum creatinine, as well as reversed various toxic chemical‐induced nephrotoxicity and oxidative damage by exhibiting excellent antioxidative properti
"highlight2" >*RenoP↑,
"highlight2" >*CRM↑, its potency in treating aging disorders and its role as a mimic of caloric restriction.

3263- Lyco,    Lycopene protects against myocardial ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening
- in-vitro, Nor, H9c2 - in-vitro, Stroke, NA
"highlight2" >*Apoptosis↓, LP pretreatment significantly increased cell viability, reduced myocardial infarct size and decreased the apoptosis rate.
"highlight2" >*MMP↑, decrease of ΔΨm were attenuated by LP and the expressions of cytochrome c, APAF-1, cleaved caspase-9 and cleaved caspase-3 were also decreased by LP
"highlight2" >*Cyt‑c↓,
"highlight2" >*APAF1↓,
"highlight2" >*cl‑Casp9↓,
"highlight2" >*cl‑Casp3↓,
"highlight2" >*Bcl-2↑, LP treatment markedly increased Bcl-2 expression, decreased Bax expression and the Bax/Bcl-2 ratio.
"highlight2" >*BAX↓,
"highlight2" >cardioP↑, myocardial ischemia-reperfusion injury (MIRI). LP protects against MIRI by inhibiting MPTP opening, partly through the modulation of Bax and Bcl-2.

3534- QC,  Lyco,    Synergistic protection of quercetin and lycopene against oxidative stress via SIRT1-Nox4-ROS axis in HUVEC cells
- in-vitro, Nor, HUVECs
"highlight2" >*ROS↓, especially quercetin-lycopene combination (molar ratio 5:1), prevented the oxidative stress in HUVEC cells by reducing the reactive oxygen species (ROS) and suppressing the expression of NADPH oxidase 4 (Nox4), a major source of ROS production.
"highlight2" >*NOX4↓, Quercetin-lycopene combination could interact with SIRT1 to inhibit Nox4 and prevent endothelial oxidative stress
"highlight2" >*Inflam↓, quercetin-lycopene combination downregulated inflammatory genes induced by H2O2, such as IL-17 and NF-κB.
"highlight2" >*NF-kB↓, NF-κB p65 was activated by H2O2 but inhibited by the quercetin-lycopene combination.
"highlight2" >*p65↓,
"highlight2" >*SIRT1↑, quercetin and lycopene combination promoted the thermostability of Sirtuin 1 (SIRT1) and activated SIRT1 deacetyl activity
"highlight2" >*cardioP↑, The cardioprotective role of SIRT1
"highlight2" >*IL6↓, LYP: Q = 1:5), interacted with deacetylase SIRT1 to inhibit NF-κB p65 and Nox4 enzyme, downregulated inflammatory cytokines such as IL-6 and pro-inflammatory enzymes such as COX-2, and suppressed ROS elevation activated by H2O2.
"highlight2" >*COX2↓,


* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 80

Results for Effect on Cancer/Diseased Cells:
Akt↓,5,   Akt↝,1,   p‑Akt↓,2,   Akt2↓,1,   angioG↓,2,   AntiCan↑,8,   AntiDiabetic↑,1,   antiOx↓,2,   antiOx↑,8,   AP-1↓,1,   APC↑,1,   Apoptosis↓,1,   Apoptosis↑,13,   ARE↑,1,   BAX↓,1,   BAX↑,6,   BAX↝,1,   Bax:Bcl2↑,4,   BBB↑,1,   Bcl-2↓,5,   Bcl-2↑,1,   BioAv↓,3,   BioAv↑,4,   BioAv↝,1,   BP↓,1,   CA125↓,1,   cardioP↑,4,   Casp3↑,6,   cl‑Casp3↑,1,   Casp7↑,1,   Casp9↑,1,   cl‑Casp9↑,1,   Catalase↑,3,   CDK2↓,4,   CDK2↑,1,   CDK4↓,4,   chemoP↑,3,   ChemoSen↓,1,   ChemoSen↑,9,   CHK1↓,1,   Chk2↓,1,   CIP2A↓,1,   cMyc↓,3,   COX2↓,7,   CycB↓,1,   cycD1↓,11,   CycD3↓,1,   cycE↓,4,   cycE↑,1,   cycE1↓,1,   Cyt‑c↑,2,   DNAdam↓,2,   DNAdam↑,3,   Dose↓,1,   Dose↑,2,   Dose↝,3,   E-cadherin↓,1,   E-cadherin↑,1,   eff?,1,   eff↓,2,   eff↑,11,   EGFR↓,1,   EMT↓,3,   ERK↓,3,   ERK↑,1,   p‑ERK↓,1,   EZH2↓,1,   FAK↓,2,   FOXO3↓,1,   G6PD↓,1,   Glycolysis↓,1,   GPx↑,4,   GR↑,1,   GSH↓,1,   GSH↑,3,   GSK‐3β↓,1,   p‑GSK‐3β↓,1,   GSR↑,1,   GSTA1↑,1,   GSTs↑,1,   hepatoP↑,1,   Hif1a↓,2,   HO-1↑,1,   IFN-γ↑,1,   IGF-1↓,1,   IGF-1R↓,1,   IL1↑,2,   IL10↓,2,   IL10↑,1,   IL12↓,1,   IL1β↓,3,   IL2↑,1,   IL4↓,1,   IL4↑,2,   IL6↓,4,   Inflam↓,4,   iNOS↓,2,   ITGA5↓,2,   ITGB1↓,2,   JAK1↓,2,   JNK↓,1,   Keap1↝,1,   Ki-67↓,1,   LDL↓,2,   lipid-P↓,2,   MAPK↓,3,   MDA↓,1,   MDA↑,1,   MMP↓,3,   MMP2↓,4,   MMP7↓,3,   MMP9↓,10,   MMPs↓,1,   MPO↓,1,   mtDam↑,1,   mTOR↓,4,   mTOR↝,1,   p‑mTOR↓,1,   N-cadherin↓,1,   neuroP↑,2,   NF-kB↓,12,   NF-kB↑,1,   NF-kB↝,1,   NO↓,1,   NOX↓,1,   NOX4↓,1,   NRF2↓,1,   NRF2↑,3,   NRF2↝,2,   OCR↓,1,   OS↑,2,   P21↓,1,   P21↑,6,   p27↓,1,   p27↑,3,   p38↓,1,   P450↓,1,   P53↓,2,   P53↑,5,   P53↝,1,   p65↓,1,   cl‑PARP↑,2,   PCNA↓,3,   PDGF↓,1,   PGE2↓,6,   PI3K↓,2,   PI3K↝,1,   p‑PI3K↓,1,   PPARγ↓,1,   PPARγ↑,3,   PSA↓,3,   PSA∅,1,   QoL↑,1,   RadioS↓,1,   RenoP↑,1,   Rho↓,1,   Risk↓,7,   ROS↓,13,   ROS↑,13,   ROS⇅,3,   i-ROS↓,1,   mt-ROS↑,1,   selectivity↑,4,   SIRT1↑,1,   SOD↓,1,   SOD↑,3,   Sp1/3/4↓,1,   STAT3↓,5,   survivin↓,2,   TIMP1↑,2,   TIMP2↑,2,   TNF-α↓,5,   TNF-α↑,1,   TP53↑,1,   TumCA↓,1,   TumCCA↓,2,   TumCCA↑,9,   TumCG↓,6,   TumCI↓,5,   TumCMig↓,3,   TumCP↓,10,   TumCP↑,1,   tumCV↓,3,   TumMeta↓,1,   TumMeta↑,1,   TumVol↓,1,   TumW↓,1,   VEGF↓,2,   Wnt↓,4,   β-catenin/ZEB1↓,4,   β-TRCP↑,1,   γH2AX↓,1,  
Total Targets: 192

Results for Effect on Normal Cells:
ACC↓,1,   Akt↓,2,   Akt↑,2,   ALAT↓,1,   AMPK↑,1,   angioG↓,1,   AntiAg↑,3,   AntiCan↑,5,   antiOx↑,28,   APAF1↓,1,   Apoptosis↓,4,   ARE↑,1,   AST↓,1,   Aβ↓,1,   BACE↓,1,   BAX↓,2,   BBB↑,2,   Bcl-2↑,2,   BDNF↑,6,   BioAv↓,4,   BioAv↑,6,   BioAv↝,4,   BP↓,2,   Ca+2↓,1,   Ca+2↝,1,   cardioP↑,8,   Casp3↓,1,   cl‑Casp3↓,1,   Casp9↓,1,   cl‑Casp9↓,1,   Catalase↑,4,   Catalase↝,1,   chemoP↑,1,   cognitive↑,4,   COX2↓,6,   creat↓,1,   CRM↑,1,   Cyt‑c↓,1,   DNAdam↓,2,   Dose?,1,   Dose↑,1,   Dose↝,3,   eff↑,6,   ER Stress↓,1,   ERK↓,1,   FASN↓,1,   GPx↑,5,   GPx↝,1,   GR↝,1,   GSH↑,5,   GSH/GSSG↓,1,   GSR↑,1,   GSTs↓,1,   GSTs↑,2,   GutMicro↑,1,   H2O2↓,1,   Half-Life↑,2,   hepatoP↑,1,   HO-1↑,5,   ICAM-1↓,2,   IFN-γ↓,1,   IL1↓,4,   IL10↓,1,   IL10↑,1,   IL12↓,1,   IL1β↓,5,   IL22↓,1,   IL6↓,8,   IL8↓,3,   IL8↑,1,   Inflam↓,13,   iNOS↓,2,   JNK↓,2,   Keap1↓,1,   Ki-67↓,1,   LDL↓,2,   lipid-P↓,4,   MAPK↓,2,   MDA↓,4,   memory↑,4,   MMP↓,1,   MMP↑,1,   MMP2↓,1,   MMP2↑,1,   MMPs↓,1,   MPO↓,1,   mtDam↓,3,   mTOR↓,1,   neuroP↑,10,   NF-kB↓,10,   NLRP3↓,1,   NO↓,3,   NOX4↓,2,   NQO1↑,3,   Nrf1↑,1,   NRF2↓,1,   NRF2↑,9,   OCR↓,1,   p38↓,2,   P450↑,1,   p62↑,1,   p65↓,1,   PI3K↑,2,   PSD95↑,1,   Pyro↓,1,   Rac1↑,1,   radioP↑,2,   RAGE↓,1,   RenoP↑,3,   Risk↓,2,   ROCK1↓,1,   ROS↓,19,   ROS↑,1,   ROS⇅,4,   SIRT1↑,1,   SOD↑,6,   SOD↝,1,   SREBP1↓,1,   STAT3↓,1,   TAC↑,2,   tau↓,1,   TGF-β1↑,1,   TIMP2↑,1,   TLR2↓,1,   TLR4↓,1,   TNF-α↓,10,   toxicity∅,2,   TrkB↑,1,   uPA↓,1,   VCAM-1↓,1,   VEGF↓,1,   VitC↑,1,   VitE↑,1,  
Total Targets: 133

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:119  Target#:%  State#:%  Dir#:%
  wNotes=on  sortOrder:rid,rpid

 

Home Page